The impact of a lack of medical explanation for pain, 'medically unexplained' comorbid conditions, and ethnicity on CBT therapists' judgments of pain and treatment decisions by Jones, BF
 
 
 
 
 
The impact of a lack of medical explanation for pain, 
‘medically unexplained’ comorbid conditions, and ethnicity 
on CBT therapists’ judgments of pain  
and treatment decisions 
 
Brittni F Jones 
 
D.Clin.Psy thesis (Volume 1), 2016 
University College London  
2 
 
UCL Doctorate in Clinical Psychology 
Thesis declaration form 
 
I confirm that the work presented in this thesis is my own. Where information has 
been derived from other sources, I confirm that this has been indicated in the thesis. 
 
 
Signature:  
 
Name: Brittni F Jones 
Date: June 17th, 2016 
  
 3 
 
Overview 
This three-part thesis reviews the effectiveness of cognitive behavioural 
therapies for medically unexplained symptoms on healthcare use, investigates the 
impact of a lack of a medical explanation for pain, ‘medically unexplained’ comorbid 
conditions, and ethnicity on CBT therapists’ judgments of pain and treatment 
decisions, and discusses the challenges that were faced in the conducting and 
reporting of this research. 
Part one of this volume is a review and meta-analysis of 16 randomised 
controlled trials of cognitive behavioural interventions for people with medically 
unexplained symptoms. Borderline significant effects were found for one analysis 
each of reduced healthcare contacts/resource use, as well as for medication use. 
There was no significant effect found for reduced medical investigations.  
Part two of this volume is an empirical study that investigates the impact of a 
lack of a medical explanation for pain, ‘medically unexplained’ comorbid conditions, 
and ethnicity on CBT therapists’ judgments of pain and treatment decisions. Small, 
but significant effects were found for the impact of a lack of a medical explanation 
for pain and comorbid conditions on CBT therapists’ estimations of pain severity and 
exaggeration. A large effect was found for the impact of comorbid conditions on 
estimations of pain being caused by a mental health problem. These factors were 
also found to have an impact on treatment decisions. No effect on pain judgments 
was found for the variable of ethnicity, but ethnicity was found to have an impact on 
treatment decisions.  
Part three is a critical appraisal of the literature review and research process as a 
whole. It contains some personal reflections on the different stages of research and 
the challenges that were faced.  
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Part 1: Literature Review 
Effectiveness of cognitive behavioural therapies for medically 
unexplained symptoms in reducing healthcare use:  
systematic review & meta-analysis. 
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Abstract 
Background: Studies have reported that medically unexplained symptoms tend to 
be associated with increased healthcare use, and this can be a drain on resources 
and a potential source of harm to patients. This finding is often used as a 
justification for the funding and study of psychological interventions for medically 
unexplained symptoms, yet there has been no systematic review that has 
specifically examined the efficacy of psychological interventions in reducing 
healthcare use. Aims: To conduct a systematic review and meta-analysis to 
evaluate the effectiveness of cognitive behavioural therapies for medically 
unexplained symptoms in reducing healthcare use. Method: The search from a 
previous systematic review was updated and expanded. 19 randomised controlled 
trials were found that reported health care use, and 16 of these provided data for 
meta-analysis. Results: Borderline significant effects for cognitive behavioural 
therapies compared to active, treatment as usual and waiting list controls in 
reducing healthcare contacts and medication use. No benefits were found for 
reduction in medical investigations. Conclusions: These results indicate that 
cognitive behavioural interventions are not yet delivering on promises to reduce 
healthcare use in people with medically unexplained symptoms. The imprecise use 
of medically unexplained symptoms as a diagnostic label may impact on the 
effectiveness of interventions, and it is likely that the diversity and complexity of 
these difficulties may necessitate a more targeted approach.  
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1. Introduction 
Despite increasingly rapid advances in biomedical science, symptoms and 
disorders that are described as medically unexplained remain common (Konnopka 
et al., 2012). A recent meta-analysis concluded that up to 49% of patients seen in 
primary care experience at least one medically unexplained symptom, and up to 
34% would meet criteria for a somatoform disorder (Haller et al., 2015). This is not a 
new phenomenon; most health conditions were medically unexplained prior to the 
20th century. However, as confidence has grown in the increasingly powerful and 
complex scientific methods developed to examine the physical body, so too has 
frustration and disbelief in symptoms that lie outside the sphere of our 
understanding.  
Out of this struggle, new diagnoses and terminology have been used for 
describing what we do not fully understand: psychosomatic, somatoform, functional, 
and medically unexplained symptoms (MUS) or conditions are just some of these. 
Whilst the DSM and ICD focus on somatoform disorders, and policy-makers and 
service commissioners tend to focus on medically unexplained symptoms, the terms 
are broad and overlapping. All essentially describe the same thing: symptoms or 
symptom clusters that are deemed to be unexplained or inadequately explained by 
current science (Smith & Dwamena, 2007). These are diagnoses by exclusion that 
are in theory given once all medical tests have been exhausted and no physical 
cause can be identified (Brown, 2007; Price, 2008). 
Giving these symptoms a categorisation or name, however, does not 
ameliorate the frustration they cause for the people who experience them or those 
tasked with providing treatment. Doctors have been shown to struggle with patients 
they cannot definitively diagnose and effectively treat (Chew-Graham et al., 2008; 
Mathers et al., 1995). Treating people who report symptoms for which no obvious 
structural abnormalities can be found, but who frequently attend appointments in 
states of distress and desperation, can leave health professionals feeling helpless 
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and inadequate. They tend to doubt the authenticity of patients’ experiences rather 
than the adequacy of their ‘objective’ tests for pathology, and suspect that patients 
are being deceptive or wasting resources (Shattock et al., 2013).  
Patients also generally expect that doctors and scientists can at the very least 
determine the cause of their symptoms, if not also offer some sort of treatment, cure 
or relief. Experiences such as chronic pain and fatigue are debilitating and have a 
significant impact on people’s ability to live their lives normally. When these 
experiences cannot be explained or treated, however, they can generate anxiety, 
helplessness, and hopelessness (Nettleton, 1982; Rhodes et al., 1999). Patients 
with medically unexplained symptoms often say they feel disbelieved, or that they 
are being wrongfully accused of having a mental health problem rather than a ‘real’ 
physical health problem (Sim & Madden, 1982; Stone et al., 2002). As a result, they 
can feel angry and resentful towards the doctors they feel should believe them and 
do more to help. 
However, there are advances in explaining the unexplained. Some symptom 
clusters are so frequently observed that, although they are still classified as 
medically unexplained, defining features have been identified and theories about 
their aetiology are being developed or are now well established by science. 
Research on Chronic Fatigue Syndrome (CFS), for example, has indicated that it 
may be associated with autoimmune, adrenal, and psychosocial factors that are 
suggestive of a complex, multi-system aetiology (Hyong et al., 2006). Likewise, the 
gate-control theory of chronic pain has shown that the experience of pain is not 
dependent on the presence of injury, but rather on complex interactions between the 
brain, spinal cord, and peripheral nervous system (Melzack & Wall, 1965; Moayedi 
& Davis, 2013). Beyond this, scientists are grappling with how to explain the 
experience of sensations in a limb that no longer or never existed (Saadah & 
Melzack, 1994), an unexplained itch so severe that the sufferer can scratch through 
their skull and into their brain while they sleep (Gawande, 2008; Wood et al., 2009), 
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and symptom relief from a placebo, even when the person taking it is aware that it is 
a placebo (Knecht et al., 1996; Schäfer et al., 2015). 
These developments generate new hope for patients and doctors who 
struggle every day with medically unexplained symptoms. However, this gap 
between theory and knowledge has occurred on countless occasions over the 
history of medicine, and researchers, doctors and health policy advisors would be 
wise to remain cautious. There are many instances when theories about disease 
were found to be wrong only after harm was done to patients. For example, prior to 
developments in the late 1800s, the prevailing theory about infectious disease was 
that it was spread through ‘miasmas’, or noxious odours (Tulodziecki, 2011). In the 
UK, this prompted public health campaigns to promote the use of indoor sewer 
systems that would remove odorous excrement from people’s homes via the water 
supply, with now obvious negative consequences for water-borne diseases such as 
cholera. However, scientists and public health officials were so wedded to this 
theory that, even after significant evidence was presented to discredit it during the 
1854 Broad Street cholera epidemic in London, they continued practices that 
undoubtedly contributed to an increase in deaths due to the disease (Paneth et al., 
1998). Thus, in this case, actions based on an incorrect theory were worse than 
doing nothing.    
Today, people who experience symptoms or conditions that are medically 
unexplained are potentially vulnerable to unintended harm by medical professionals 
and researchers for a number of reasons. Firstly, for some patients, it remains a 
possibility that they are experiencing a medically explained condition that is difficult 
to diagnose and for which a lack of appropriate treatment could put their health at 
risk (Smith et al., 2007). For example, inflammatory and autoimmune conditions 
such as Rheumatoid Arthritis can be difficult to detect and may be misdiagnosed as 
a medically unexplained condition such as Fibromyalgia, potentially resulting in 
higher levels of joint damage (Fitzcharles & Boulos, 2003). Therefore, it is essential 
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that doctors rule out medically explained conditions, and remain open to the 
potential need for further investigations and changes in diagnosis.   
On the other hand, patients with medically unexplained symptoms could 
potentially be harmed by overly intensive, invasive or unnecessary investigations 
and treatments (Price, 2008). Not only are the benefits of many of these treatments 
and investigations questionable, but they can also raise patients’ anxiety about their 
health, and frustration with a healthcare system that seems unable to offer an 
explanation for their experiences or relief from their symptoms (Lipsitt et al., 2014). 
Aside from physical harm, unnecessary treatments and investigations are also a 
drain on limited financial and healthcare resources, whether that cost is borne by the 
individual patient or society as a whole (Konnopka et al., 2012). 
Finally, whilst conditions remain unexplained, many researchers, doctors and 
patients understandably choose to develop, deliver and engage in treatments that 
are based on as yet unproven theories about the aetiology of symptoms. This is 
often a pragmatic and sensible choice that results in the delivery of treatments 
based on sound theory and research-based evidence, to patients who otherwise 
have limited options or hope of symptom relief. Nevertheless, these treatments still 
lie in the gap between theory and knowledge that so often in medical history has 
had negative results. In the most basic sense, medically unexplained conditions are 
to the present day what cholera was for people in the 1800s.  
For MUS, the picture is further complicated by the imprecision and broad use 
of the term and the multiplicity of radically different - often unsubstantiated - theories 
about causation. For example, although the gate-control theory of pain is now well 
established by science (Moayedi & Davis, 2013), many health professionals and 
guidance documents (not to mention the general public) continue to believe and 
promote the psychodynamic theory  – for which there is no scientific evidence - that 
pain can be the manifestation of suppressed emotion or mental health difficulties 
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(Brown, 2007; Department of Health, 2014; Commissioning Support for London, 
2010; Nemiah et al., 1976; Rief & Broadbent, 2007; Smith et al., 2007).  
Further, when ‘diagnosing’ symptoms as medically unexplained, medical 
evidence based on the physical structures of the body that can be easily observed 
or measured is often given precedence over evidence of a patient’s functioning. In 
other cases, it seems that some conditions may continue to be classified as 
medically unexplained, not because there is insufficient scientific evidence of a 
causal mechanism, but because the medical community struggles to treat the 
condition or the patients seem to benefit in some way from psychological 
treatments. 
For these reasons, it is vital that methodologically valid and thorough research 
is conducted not only to investigate the aetiology of medically unexplained 
symptoms, but also to examine the effectiveness of the treatments that are 
delivered and the processes by which these interventions bring about change. 
There are many, often conflicting theories about medically unexplained symptoms 
(Brown, 2007; Rief et al., 2007). Some models emphasise the impact of illness 
beliefs and avoidance of physical activity (Deary, Chalder, & Sharpe, 2006; Rief et 
al., 1999), while others, despite the complete lack of evidence, continue to maintain 
that physical symptoms can be the manifestation of suppressed emotion (Nemiah et 
al., 1976). As such, studies based on these different theories are likely to have 
different outcome measures. Research based on the former model will likely utilise 
measures of cognitions and beliefs, whereas studies based on the latter theory will 
probably include measures of emotional avoidance and psychological difficulties. 
Neither are necessarily wrong choices, but they are inadequate if not paired with 
more robust measures of target symptoms and outcomes, and recording of adverse 
events (Brown, 2007; Williams, Eccleston & Morley, 2012). Otherwise, these studies 
could be likened to 1800s officials in London measuring their risk of infection with 
their noses. 
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In the case of medically unexplained symptoms and conditions, many of the 
studies of the efficacy of psychological interventions tend to measure treatment 
success in terms of the factors that the treatment was intended to change, such as 
illness beliefs, self-rated quality of life, and mood. However, they often do not 
assess physical functioning or wellbeing, or they do so in a way that does not reflect 
meaningful changes in functioning from the participants’ perspective (Agardy, 2013). 
Measures specifically designed for medically unexplained symptoms, because of 
their theoretical underpinning, are often intrinsically linked to mood, which can 
impact on the responses participants give in terms of their physical functioning 
(Tomenson et al., 2013). And, far too frequently, research on medically unexplained 
symptoms relies exclusively on self-report measures. It is disappointing that more 
robust ways of measuring improvement are not developed and utilised and, as a 
result, a study participant could continue to live with significant levels of impairment, 
despite being presented as statistically improved in a research paper.  
Due to the broad and often diffuse and overlapping diagnoses associated with 
the category of medically unexplained symptoms, as well as - often - the lack of 
physical markers or tests for measuring outcomes, it can be difficult to identify 
robust measures of treatment efficacy (Brown, 2007). Despite this, health policy 
makers and advisors have tended thus far to utilise increasingly broad and inclusive 
definitions for medically unexplained symptoms, and to commission services based 
on these categorisations (Department of Health, 2011, Department of Health, 2014; 
Commissioning Support for London, 2010). Whilst this decision is questionable and 
the framework it creates is likely not based on our best scientific understandings of 
‘medically unexplained’ symptoms and conditions, it remains the norm. As such, it is 
the mandate that must be worked within for the time being.  However, it complicates 
the picture for researchers and treatment providers who work within these 
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healthcare systems, as few outcome measures will be relevant to all medically 
unexplained symptoms.  
One potentially more robust outcome that could be proposed is healthcare 
utilisation. People with medically unexplained symptoms are almost universally cited 
as high utilisers of healthcare resources, and this is considered to be a potential 
source of harm to patients, as well as a potential waste of resources (Konnopka et 
al., 2012; Price, 2008). Healthcare utilisation is an appropriately broad outcome that 
is likely to apply to most people with medically unexplained symptoms, and can be 
objectively measured through medical records. It also has specific applicability to 
the successful treatment of medically unexplained symptoms that, particularly in 
severe cases, are associated with unnecessary and potentially invasive or 
detrimental investigations and treatments.  
In addition, a review of the literature on medically unexplained symptoms 
indicates that a great deal of service commissioning and studies of treatment 
effectiveness may in large part be justified by citing the costs associated with high 
healthcare utilisation. As a result, it would be prudent to measure whether the 
proposed interventions are indeed cost-effective. It is unclear how often this is done, 
although previous Cochrane reviews that focused on treatments for chronic pain or 
medically unexplained symptoms (or conditions deemed to be medically 
unexplained) either did not include healthcare use as an outcome (Bernardy et al., 
2013; Zijdenbos et al., 2009) or did not meta-analyse the outcome due to a lack of 
data (Price et al., 2008). In a review by van Dessel et al. (2014), six of the studies 
reviewed provided data on post-treatment healthcare use, and no significant effect 
was found. Another Cochrane review on chronic pain (Williams et al., 2012) was 
followed up with an additional meta-analysis that found some moderate effects of 
psychological treatments on healthcare use in patients with chronic pain (Pike et al., 
2016).  
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This review and meta-analysis will aim to investigate healthcare utilisation as 
an outcome in studies of interventions for medically unexplained symptoms. The 
literature search will draw from the studies included in a recent review of non-
pharmacological interventions for somatoform disorders and medically unexplained 
symptoms (van Dessel et al., 2014). The search will also be updated and expanded 
to include all categories and diagnoses associated with medically unexplained 
symptoms (rather than just those that would only meet criteria for a somatoform 
disorder as in the van Dessel et al. [2014] review). As Cognitive Behavioural 
Therapy (CBT) is the most evidence-based intervention for both explained and 
unexplained conditions (Commissioning Support for London, 2010; Naylor, 
Parsonage, McDaid, Knapp, Fossey & Galea, 2012; Williams et al., 2012), the 
search will be limited to only that type of intervention. This review will also record the 
proportion of papers that cite healthcare use as a justification for their research, but 
do not measure it as an outcome.  
2. Method 
2.1 Search strategy 
The van Dessel et al. review (2014) was first searched for trials reporting 
healthcare use as outcomes as well as at least one trial arm of a CBT-based 
intervention.  The search from that review was then extended in three ways. Firstly, 
as this review is focused on trials of CBT-based treatments, search terms were 
added to specifically capture these studies. Secondly, although the previous review 
had focused on multiple MUS and excluded participants with “only one specific 
functional syndrome or symptom”, this review was intended to examine the category 
of MUS as a whole. The search was therefore extended to encompass all conditions 
currently classified as ‘somatic’, ‘functional’ or ‘medically unexplained’. Finally, the 
Cochrane Central Register of Control Trials (CENTRAL 2013), EMBASE, PsycINFO 
and MEDLINE were searched using the extended search strategy from January 
2005 to December 2015. Appendix 1 includes an example search strategy (minor 
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adjustments were required for different databases). No additional restrictions were 
applied.  
2.2 Inclusion and exclusion criteria 
2.2.1 Types of studies 
As in the van Dessel et al. review (2014), studies were included if they were 
full reports of randomised controlled trials (RCTs) or cluster randomised controlled 
trials (CRCTs), and were published in a peer-reviewed scientific journal.  
2.2.2 Participants 
Also in common with the previous review, participants were required to be 18 
years or older and to have MUS as their primary problem. However, this review 
used the definition of MUS in the broadest sense, and therefore also included 
participants with not only diagnoses of multiple MUS or somatoform disorders, but 
also with single medically unexplained symptoms or disorders such as fibromyalgia 
(FMS), chronic fatigue syndrome (CFS), irritable bowel syndrome (IBS), 
temporomandibular disorders, and chronic pain (of at least 3 months duration in any 
body site). Participants with chronic pain or other symptoms (e.g. fatigue) 
associated with malignant disease or established medical diagnoses (e.g. 
rheumatoid arthritis) were excluded.   
2.2.3 Interventions 
Rather than including all non-pharmacological interventions, studies were 
included for this review only if the primary experimental intervention was based on 
CBT. This could include behavioural therapy (e.g. graded exercise, relaxation), 
third-wave CBT (e.g. mindfulness, acceptance and commitment therapy: ACT), and 
rehabilitation or ‘stress reduction’ programmes with a major component of CBT. In 
order to ensure that an appropriate level of fidelity to the model was achieved, it was 
required that these interventions be delivered or supervised by a qualified 
psychologist or healthcare professional with a recognised qualification in CBT. It 
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was also required that the primary mode of delivery of the intervention was face-to-
face.  
In addition to having a treatment arm based on CBT, eligible trials were 
required to have at least one comparator arm of another active intervention, 
attention or waiting list control, or treatment as usual. 
2.2.4 Outcomes 
Finally, included trials were required to measure healthcare utilisation as at 
least one outcome. All studies that reported measuring this outcome were included 
in the review. However, given the heterogeneous ways of measuring healthcare use 
(and in some cases, the failure to report full data), not all studies contributed usable 
data for analyses. Data were eligible for analysis regardless of how a patient 
accessed health services (e.g. self-referral, medical referral), the type of service 
used (e.g. outpatient visits, hospital admissions, procedures or tests), or how it was 
recorded (e.g. self-report, medical records). The data collected was in the form of 
health service visits, medication use, and number of treatments or medical 
investigations (diagnostic procedures or tests, e.g. laboratory tests, MRI, X-ray). 
As participants engaged in an active treatment condition were regularly in 
contact with a healthcare service or professional, the use of other healthcare 
services during the course of a trial would be expected to decrease or remain stable 
over the course of treatment. As a result, eligible trials for analyses were required to 
present data on post-treatment healthcare utilisation.  
2.3. Data collection and management 
2.3.1 Study selection 
First, duplicate records from the literature search were identified and 
discarded. The titles and abstracts of studies identified from the search were then 
screened, and those that obviously did not meet the inclusion criteria were 
excluded. The full texts of the remaining trials were examined, and studies were 
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identified for inclusion and exclusion. During this process, multiple reports on the 
same study were identified and collated.  
The reasons for exclusion of studies were recorded. The number of reports 
that cited healthcare utilisation in the rationale for the study but did not use it as an 
outcome was also recorded.  
2.3.2 Data extraction and management 
Data were extracted on the final set of papers, including descriptive 
characteristics of participants, treatments and outcome measures. Further data from 
3 authors (McCracken et al., 2013; Schmidt et al., 2011; Sleptsova et al., 2013) had 
been obtained for another review (Pike et al., 2016) and were shared for this 
analysis.  
2.4. Risk of bias  
A quality rating scale that generates numerical quality scores could have been 
used to assess the risk of bias for the trials in this review. However, these types of 
scales produce a composite score, wherein studies with very different qualities and 
risk of bias issues may attain an equal score. As a result, these scales can produce 
arbitrary results that do not reflect the most meaningful analysis of the quality of 
studies in a review. As a result, it was decided that each study would be individually 
assessed for bias using adapted Cochrane principles (Higgins & Green, 2011).  
Of the suggested Cochrane risk of bias categories, performance bias as 
excluded because it is not possible to blind therapists and patients to the delivery or 
receipt of psychological therapy. The remaining suggested risk of bias categories of 
selection bias (randomised selection and allocation concealment), detection bias 
(outcome assessment blinding), reporting bias (selective reporting of results), and 
attrition bias (participant drop-out) were utilised as suggested in Cochrane guidance. 
In line with another meta-analysis on treatment of pain in a specific population 
(Baird et al., 2016) additional attention was paid to the way that studies managed 
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incomplete data (attrition bias). In addition, studies were examined for bias related 
to insufficient size and power, as well as the quality of the treatment delivered.  
Attrition bias is particularly important to consider in research on psychological 
treatments for medically unexplained symptoms. Understandably, participants who 
have struggled with medically unexplained symptoms could interpret (and, 
sometimes, rightly so) psychological treatments as a confirmation that health 
professionals believe their symptoms are due to a mental health problem. As a 
result, many may not engage in treatment, either from the start or through dropping 
out partway through the intervention. Participants may also drop out of treatment if 
they are experiencing adverse effects or do not feel that they are benefiting. As a 
result, in order to reduce the risk of inflating or over-generalising treatment 
outcomes, it is imperative that studies on medically unexplained symptoms pay 
particular attention to the way in which they select participants and handle the data 
from those who do not complete treatment.  In this review, studies were assessed 
as ‘low risk’ if less than 10% of participants did not complete the study or an 
intention to treat (ITT) analysis was completed with the conservative ‘baseline 
measure carried forward’, ‘unclear risk’ if more than 10% of participants did not 
complete the study and an algorithm to estimate missing values was used, or ‘high 
risk’ if more than 10% dropped out and only a ‘completer’ analysis was used.  
Due to the broad use of the term medically unexplained symptoms and the 
difficulties this can generate in research on interventions, it is also important that 
studies utilise power calculations and ensure that their treatment groups are 
adequately sized in order to detect treatment effects.  Studies were deemed to have 
a ‘low risk’ of bias due to insufficient size if they had reported a power analysis for 
their study and had met the size requirement, ‘unclear risk’ of bias if they reported a 
power analysis but did not meet the size requirement, and ‘high risk’ of bias if they 
did not report a power analysis and the size of the study was not clearly adequate.    
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As with all research on treatment effectiveness, but particularly in the case of 
non-pharmacological treatments, it is important to ensure that the specified 
intervention was actually delivered to participants and was of sufficient quality. In the 
case of medically unexplained symptoms, similar interventions could be based on 
very different theories about aetiology and maintaining factors and therefore have 
varied implementation, and it is important that this is critically examined when 
analysing treatment effects. In this review, studies that did not utilise suitably 
qualified healthcare professionals to deliver the specified treatment were excluded 
outright due to the risk of insufficient treatment quality. Trials that used a suitably 
qualified healthcare professional, but did not make any effort to check the quality 
and fidelity of treatment to the specified model, were assessed as having a ‘high 
risk’ of bias. Studies were deemed to have an ‘unclear risk’ of bias if they stated that 
treatment fidelity or quality was checked, but did not provide sufficient information 
on this. A rating of ‘low risk’ of bias was only given to trials that clearly stated how 
treatment quality and fidelity to the model were assessed, and adequately reported 
the results of this.   
The ‘Risk of bias’ tool in the Cochrane Collaboration’s RevMan5.3 software 
(The Cochrane Collaboration, 2014) was used to complete a risk of bias table for 
each study.  
2.5. Meta-analysis of treatment effect 
The RevMan5.3 software was also used to analyse data for the meta-analysis. 
Treatment effects for continuous data were estimated using standardized mean 
differences (through the extraction of means, standard deviations, and sample 
sizes). Treatment effects for dichotomous data were estimated using odds ratios 
(through the extraction of events data and sample sizes). Due to the diversity of 
data extracted, both continuous and dichotomous data were analysed using random 
effects. All calculations were made using 95% confidence intervals.  
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In the event that a study had two or more treatment groups that were CBT-
based and met the inclusion criteria for this review, and/or two or more comparison 
groups, these were combined into a single treatment or comparison group. The 
heterogeneity of data (as indicated by the I2 statistic) was calculated in RevMan and 
interpreted using Cochrane principles (The Cochrane Collaboration, 2011). 
Studies that did not provide usable data for the meta-analysis were included in 
the narrative review.  
3. Results 
3.1. Search 
The outcome and process of the literature search and study selection is 
summarised a PRISMA study flow diagram in Figure 1.  
The initial search of the van Dessel et al. review (2014) resulted in six papers 
describing trials that measured healthcare use (Kolk et al., 2004; Lidbeck, 2003; 
Martin et al., 2007; Sattel et al., 2012; Schaefert et al., 2013; Sumathipala et al., 
2008). However, only three had an exclusively CBT-based treatment arm, and two 
of these were excluded because the intervention was not delivered or supervised by 
a suitably qualified healthcare professional (rationale detailed in section 2.4) 
(Lidbeck, 2003; Sumathipala et al., 2008). Therefore, only one study from the 
previous review was included (Martin et al., 2007). The expanded and updated 
search resulted in 19 eligible trials (Allen et al., 2006; de Boer et al., 2014; Fjorback 
et al., 2013; Jensen et al., 2005; Kaapa et al., 2006; Luciano et al., 2013; Martin et 
al., 2007; McCracken et al., 2013; McCrone et al., 2008; McCrone et al., 2012; 
Meng et al., 2014; Nyenhuis et al., 2013; O'Dowd et al., 2006; Schmidt et al., 2011; 
Schröder et al., 2013; Siemonsma et al., 2013; Sleptsova et al., 2013; Thieme et al., 
2006; van Ravesteijn et al., 2013). Table 1 provides details for these studies. In 
cases where a follow-up or economic analysis was completed that contributed the 
majority of data, this paper will refer to those studies rather than the original trial.   
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Trials identified from the expanded search were excluded for the following 
reasons.  Two studies did not deliver a face-to-face intervention (Ljótsson et al., 
2011; McBeth et al., 2012). One trial recruited participants who were still in the 
acute stage of pain (Stowell et al., 2007). Another study did not utilise an adequate 
control or randomisation procedure for the purposes of this review (Thorn et al., 
2011). Finally, a further seven trials utilised interventions that were not delivered or 
supervised by a healthcare professional with a suitable qualification in psychology or 
a CBT-based treatment (Falcao et al., 2008; Froholdt et al., 2012; Goldstein et al., 
2010; Jerant et al., 2009; Lindell et al., 2008; Luo et al., 2007; Miró et al., 2011). 
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Figure 1: PRISMA Study Flow Diagram 
 
 
  
140 full-text studies examined 
121 studies excluded: 
105 – no eligible outcomes 
3 – not CBT interventions 
1 – not chronic pain 
2 – no face-to-face intervention 
1 – inadequate randomisation and 
control 
9 – intervention not 
delivered/supervised by eligible 
healthcare professional 
 
2810 studies excluded on title or 
abstract 
19 studies included: 
1 – van Dessel et al. review (2014) 
18 – extended search 
3 studies provided no  
useable data (reviewed narratively) 
16 studies included in  
meta-analysis 
3141 records identified through 
database searches 
  
28 records identified from van 
Dessel et al. review (2014) 
  
219 duplicates removed 
2950 records screened 
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Table 1. Included trials and follow-up studies: interventions, controls, and modes of 
measuring healthcare use 
Trials & Follow-ups Intervention(s) Control(s) Mode of measuring healthcare use 
Allen et al., 2006 CBT + Psychiatric 
Consultation Intervention 
(PCI) 
PCI alone Healthcare contacts  
Medical investigations 
de Boer et al., 2014 CBT  TAU Healthcare contacts 
Fjorback et al., 2012  
(cost-effectiveness study: 
2013) 
Mindfulness  TAU Healthcare contacts 
Jensen et al., 2001  
(follow-up study: 2005) 
CBT, Physical Therapy 
(PT) & Behavioural 
Medicine Rehabilitation 
 
TAU Healthcare contacts 
Kaapa et al., 2006 Multidisciplinary Team 
(MDT) Rehab 
PT Healthcare contacts 
Kennedy et al., 2005 
(cost-effectiveness study: 
McCrone et al., 2008) 
CBT + Medication Medication 
only 
Healthcare contacts 
Luciano et al., 2011 
(follow-up study: 2013) 
CBT TAU Healthcare contacts/costs 
Medication costs 
Medical investigation costs 
Martin et al., 2007 CBT TAU Healthcare contacts 
Medication use 
Meng et al., 2015 CBT TAU Healthcare contacts, 
Medication use 
Medical investigations 
McCracken et al., 2013 Acceptance and 
Commitment Therapy 
(ACT) 
TAU Healthcare contacts 
Nyenhuis et al., 2013 CBT Internet & 
Bibliotherapy 
interventions 
Healthcare contacts 
O’Dowd et al., 2006 CBT TAU & 
Education 
Support Group  
Healthcare contacts 
Medication use 
Combined costs 
Schmidt et al., 2011 Mindfulness-based 
Stress Reduction 
(MBSR) 
TAU & 
Attention 
control  
Healthcare contacts 
Medication use 
Schröder et al., 2013 CBT Waitlist control Healthcare contacts 
Siemonsma et al., 2013 “Cognitive Treatment of 
Illness Perceptions” 
(CTIP) 
TAU Healthcare contacts 
Medication use 
Sleptsova et al., 2013 CBT Exercise Healthcare contacts, 
medication use, & medical 
investigations 
Thieme et al., 2006 CBT & Operant 
Behaviour Therapy 
(OBT) 
Attention 
control 
Healthcare contacts 
van Ravesteijn et al., 2013 
(cost-effectiveness study: 
2013) 
Mindfulness-based 
Cognitive Therapy 
(MBCT) 
Enhanced 
usual care 
Healthcare contacts & 
costs 
White et al., 2011 
(cost-effectiveness study: 
McCrone et al., 2012) 
CBT, Adaptive Pacing 
Therapy & Graded 
Exercise Therapy  
TAU Healthcare contacts, 
medication costs 
Note: TAU = Treatment as usual, CBT = Cognitive Behavioural Therapy 
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3.2 Participants 
The 19 studies reviewed contributed a total of 3239 participants (mean 171) at 
the start of treatment, and 2668 (mean 140) at the end. Dropout was generally 
moderate across the studies, with a mean completion rate of 82%.  
Two studies were conducted in the USA (Allen et al., 2006; Meng et al., 2014), 
and the rest in Europe. Participants had a wide age range from 18 to 75, with a 
combined average age of 45. As is commonly found in research on medically 
unexplained symptoms, the majority of participants were female (72%).  Males 
outnumbered females in only two studies (N = 729, 54% males) (Nyenhuis et al., 
2013; Siemonsma et al., 2013). Two studies had exclusively female participants (N 
= 293) (Schmidt et al., 2011; Thieme et al., 2006), and the remaining 15 studies 
recruited a majority of female patients (77%). 
3.3 Diagnoses 
Due to the broad and overlapping nature of conditions and symptoms 
described as medically unexplained, the 19 eligible trials recruited participants with 
a wide range of symptoms and complaints and used many different diagnostic 
labels.  
No studies recruited patients based on the new DSM-5 diagnoses of Somatic 
Symptom Disorder or Illness Anxiety Disorder, which no longer have the 
requirement that symptoms be medically unexplained (American Psychiatric 
Association, 2013). Four studies (N = 441) recruited patients based on DSM-IV 
diagnostic criteria (American Psychiatric Association, 1994), the most common of 
which were Undifferentiated Somatoform Disorder (N = 173), Somatization Disorder 
(N = 133), and Pain Disorder (N = 56) (Allen et al., 2006; Martin et al., 2007; 
Schröder et al., 2013; van Ravesteijn et al., 2013). Of these four studies, two did not 
report the specific physical complaints of participants (Allen et al., 2006; Martin et 
al., 2007), one (Schröder et al., 2013) reported that the most frequent complaints 
were pain, dizziness, heart palpitations and fatigue, and the final study provided a 
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breakdown of complaints, including fatigue (N = 31), pain (N = 57), gastrointestinal 
symptoms (N = 13), and neurological symptoms (N = 11). 
Nine studies included participants (N = 1172) with chronic pain or 
Fibromyalgia (a medically unexplained condition associated primarily with chronic 
pain) (de Boer et al., 2014; Jensen et al., 2005; Kaapa et al., 2006; Luciano et al., 
2011; McCracken et al., 2013; Schmidt et al., 2011; Schröder et al., 2013; Sleptsova 
et al., 2013; Thieme et al., 2006). Four of these studies exclusively included 
participants with Fibromyalgia (N = 482) (Luciano et al., 2011; McCracken et al., 
2013; Schmidt et al., 2011; Thieme et al., 2006). Amongst all nine studies, back 
and/or neck pain was a dominant complaint (N = 541).  
Several studies focused on specific disorders currently classified as medically 
unexplained. One study recruited participants diagnosed with Irritable Bowel 
Syndrome (N = 149) (Kennedy et al., 2005), three studies recruited participants 
diagnosed with Chronic Fatigue Syndrome or presenting primarily with unexplained 
chronic fatigue (N = 904), and one study recruited participants with Tinnitus (N = 
304).  
Finally, one study (Fjorback et al., 2012) recruited patients with medically 
unexplained symptoms who met criteria for a newly proposed diagnosis of Bodily 
Distress Syndrome (N = 119). Participants in this study presented variably with 
chronic fatigue syndrome, fibromyalgia, non-cardiac chest pain, irritable bowel 
syndrome, hyperventilation syndrome, and tension headache.  
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3.4 Risk of bias analysis 
Figures 2 and 3 provide overall summaries of the risk of bias for each study.  
 
Figure 2: Risk of bias graph: judgments of each risk of bias item presented as percentages 
across all included studies  
 
 
 
Figure 3: Risk of bias summary: judgments of each risk of bias item for each included study  
 
 
3.4.1 Selection bias 
Most studies were rated as low risk in terms of randomised selection of 
participants. Three studies either had potential problems with randomisation 
(Jensen et al., 2005) or did not give enough information on how randomisation was 
achieved (Schröder et al., 2013; Thieme et al., 2006). Five trials did not conceal 
group allocation or did not mention this in the report (Allen et al., 2006; Martin et al., 
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2007; McCracken et al., 2013; Schröder et al., 2013; Thieme et al., 2006), and three 
further studies did not give enough information or presented potential problems with 
how concealment was attained (McCrone et al., 2008; Meng et al., 2014; Schmidt et 
al., 2011). 
The majority of studies checked that participants in each group did not differ 
significantly on baseline characteristics, but only four studies measured participants’ 
expectations for treatment in all groups  (Allen et al., 2006; Kaapa et al., 2006; 
McCrone et al., 2012; Thieme et al., 2006).  
3.4.2 Attrition bias 
As expected from previous research and reviews, less than half of the studies 
(N = 8) either had less than 10% of participants drop out or used a conservative 
intention to treat analysis of ‘baseline measure carried forward’ (Allen et al., 2006; 
de Boer et al., 2014; Kaapa et al., 2006; Luciano et al., 2013; Martin et al., 2007; 
McCrone et al., 2012; Schröder et al., 2013; Thieme et al., 2006). The remaining 
studies (N = 11) had higher levels of attrition and conducted less conservative 
intention to treat analyses. One of these trials conducted only a ‘completer’ analysis 
and was assessed as a high risk of bias (Sleptsova et al., 2013). Another trial was 
assessed as high risk because, although the intention to treat results conflicted with 
the ‘completer’ analysis, they chose to use the ‘completer’ analysis in their 
interpretation of the study outcome (Jensen et al., 2005).  
3.4.3 Detection bias 
More than half of the trials (N  = 11) either did not attempt to blind outcome 
assessors to participants’ intervention condition (Jensen et al., 2005; Kaapa et al., 
2006; Martin et al., 2007; McCrone et al., 2008; Schröder et al., 2013; Thieme et al., 
2006; van Ravesteijn et al., 2013), had problematic concealment (de Boer et al., 
2014), or did not provide enough information on how this was achieved (Allen et al., 
2006; McCracken et al., 2013; Sleptsova et al., 2013).  
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3.4.4 Reporting bias 
All studies provided reports on all outcomes, but five of these did not provide 
complete data associated with some results (McCracken et al., 2013; Meng et al., 
2014; Nyenhuis et al., 2013; O'Dowd et al., 2006; Thieme et al., 2006). One trial was 
rated as ‘unclear’ risk of bias, as it utilised visual analogue scales and drawings to 
measure pain intensity and location, and these were not adequately described for 
interpretation of results (Sleptsova et al., 2013). The final trial was rated as ‘high’ 
risk of bias because it deviated from the protocol when reporting and analysing 
some outcomes, and this could have resulted in a positive interpretation of 
treatment effectiveness for participants who did not experience clinically meaningful 
improvement (McCrone et al., 2012). These deviations from protocol in the analysis 
and reporting of results in the McCrone et al. trial (2012) have been strongly 
criticised, and there have also been allegations regarding inadequate reporting of 
adverse events (Agardy, 2013).  
3.4.5 Size bias 
Five trials neglected to conduct a power analysis when planning recruitment 
(Allen et al., 2006; Martin et al., 2007; McCracken et al., 2013; Siemonsma et al., 
2013; Thieme et al., 2006), and two studies conducted a power analysis (initially or 
post-hoc) and were underpowered (de Boer et al., 2014; Schröder et al., 2013). One 
trial was rated as a ‘high’ risk of bias because a power analysis was conducted 
using an estimated effect size based on “previous [clinical] experience” of delivering 
the intervention, and was likely underpowered (Sleptsova et al., 2013). 
3.4.6 Treatment quality bias 
Nearly half of the studies reviewed (N = 9) made no attempt to assess 
treatment quality or fidelity to the model (de Boer et al., 2014; Kaapa et al., 2006; 
Luciano et al., 2013; Martin et al., 2007; Nyenhuis et al., 2013; O'Dowd et al., 2006; 
Schmidt et al., 2011; Thieme et al., 2006; van Ravesteijn et al., 2013). Three studies 
made some efforts to ensure treatment quality, but these were either inadequate for 
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a ‘low’ risk of bias rating or were not fully reported (Jensen et al., 2005; McCracken 
et al., 2013; Siemonsma et al., 2013). One study was rated as ‘high’ risk of bias 
because, although it took some steps to ensure treatment quality (taped sessions 
for supervision), there were significant concerns regarding the dosage of treatment 
due to a high level of non-attendance in the treatment group (McCrone et al., 2008). 
Another study made only a very minimal effort to ensure treatment quality 
(supervision), but delivered a very high dose of treatment (25, 90 minute sessions), 
and provided limited information on the treatment protocol (Sleptsova et al., 2013).  
3.5 Interventions 
As specified in the inclusion criteria, all 19 studies included a CBT-based 
treatment (see section 2.2.3 for a definition of these). Most (N = 12) described a 
CBT treatment with elements aimed at addressing both cognitive and behavioural 
factors. Of the remaining studies, three utilised a mainly behavioural treatment 
(Luciano et al., 2011; Meng et al., 2014; Sleptsova et al., 2013), three focused on 
mindfulness or mindfulness-based cognitive therapy/stress reduction (Fjorback et 
al., 2012; Schmidt et al., 2011; van Ravesteijn et al., 2013), and one study delivered 
Acceptance and Commitment Therapy (ACT) (McCracken et al., 2013).  
Most studies had two arms (N = 8), and half of these used a treatment as 
usual, or attention placebo control (Luciano et al., 2011; Martin et al., 2007; 
Siemonsma et al., 2013; Sleptsova et al., 2013). Although both ‘waiting list’ and 
‘treatment as usual’ controls were specified by studies, participants on waiting lists 
were also presumed to be receiving treatment as usual. Of the four studies that 
used an attention placebo control, three of these were considered to be of good 
quality with equal numbers of sessions and a specified activity (exercise, 
relaxation/stretching, group support) and adequate rationale presented to the 
participants (Meng et al., 2014; Sleptsova et al., 2013; Thieme et al., 2006). 
However, the quality of the attention control in the remaining study was questionable 
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(information booklet, self management), and this was reflected in the high level of 
dropout in these groups (Nyenhuis et al., 2013).  
One study combined CBT with a psychiatric consultation intervention (PCI), 
which instructed primary care physicians to see participants only during regularly 
scheduled appointments and limit additional diagnostic procedures and treatments, 
and compared this to PCI alone (Allen et al., 2006). Similarly, a study of treatment 
for IBS compared CBT and a drug treatment to drug treatment alone. Another study 
incorporated CBT into a multidisciplinary rehabilitation programme (an intensive 
package of treatment including occupational, physiotherapy, and exercise 
interventions) and compared this to individual physiotherapy (Kaapa et al., 2006). 
The remaining study compared face-to-face and Internet-delivered CBT (de Boer et 
al., 2014). 
Four trials had three arms, and three of these compared one active treatment 
to attention, placebo, or treatment as usual controls (Meng et al., 2014; O'Dowd et 
al., 2006; Schmidt et al., 2011). For all analyses of these studies, the attention, 
placebo and treatment as usual controls were combined and compared to the active 
treatment. The remaining study compared two active treatments (CBT combined 
with behaviour therapy (BT) or BT alone) with an attention control (Thieme et al., 
2006). For all analyses of this study, CBT with BT and BT alone were combined and 
compared with the attention control.  
Finally, three studies had four arms. Two of these compared CBT with 
behaviourally oriented treatments and a ‘specialist medical care’ or treatment as 
usual control (Jensen et al., 2005; White et al., 2011). As all of the behaviourally 
oriented treatments met criteria for inclusion in this review, they were combined for 
all analyses and compared to the specified controls. The last study compared face-
to-face CBT with Internet and bibliotherapy interventions as well as an ‘information 
provision’ control (Nyenhuis et al., 2013). This review did not provide usable data for 
analyses.   
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3.6 Healthcare use 
Of the 140 full-text studies examined in the literature search, over half (N = 78) 
cited high healthcare utilisation as an indicator of the need for research on medically 
unexplained symptoms in the abstract or introduction of the report. 63% of these 
studies (N = 49) did not go on to measure healthcare use as an outcome.  
Of the 19 trials that were eligible for this review, 16 studies contributed usable 
data for meta-analysis of healthcare use outcomes. All trials assessed healthcare 
use at follow-up, and this varied in length from 8 weeks to 3 years. Some studies 
assessed healthcare use at more than one time post-treatment, and in these cases 
the latest measurement was chosen. Most trials (N = 13) collected data on 
healthcare use through self-report; one used insurance company records (Sleptsova 
et al., 2013), and four collected data directly from medical records (Allen et al., 
2006; Fjorback et al., 2013; O'Dowd et al., 2006; Thieme et al., 2006).   
3.6.1 Healthcare contacts and resource use 
All sixteen studies with usable data contributed to the meta-analysis of 
healthcare contacts and resource use. Fourteen trials reported means and standard 
deviations (or data that were used to derive this information). Nine referred 
specifically to contacts with healthcare professionals (Allen et al., 2006; Kaapa et 
al., 2006; Martín et al., 2014; McCracken et al., 2013; Meng et al., 2014; Schmidt et 
al., 2011; Sleptsova et al., 2013; Thieme et al., 2006; van Ravesteijn et al., 2013), 
two to the cost of healthcare use (Fjorback et al., 2013; Luciano et al., 2013), and 
three provided data on both contacts and associated costs (McCrone et al., 2008; 
McCrone et al., 2012; O'Dowd et al., 2006). In the case of the latter three trials, data 
on healthcare contacts was used rather than costs, as that was the measure in 
common with the majority of trials in this review. The overall effect showed no 
significant difference between intervention and control in reduction of healthcare 
resource use: SMD = -0.20 (95% CI -0.42 to 0.01); z = 1.90, p = 0.06. Heterogeneity 
was high, at 79%.  
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It was observed from the raw data that was obtained from three studies 
(McCracken et al., 2013; Schmidt et al., 2011; Sleptsova et al., 2013), that the data 
for healthcare use did not have a normal distribution. In addition, the way that data 
was presented in other trials (Allen et al., 2006; van Ravesteijn et al., 2013) also 
suggested that it was skewed. There was no evidence in the reports of these 
studies that any efforts were made to correct for this deviation from normality. This 
data was not excluded from the meta-analysis, because the method of analysis 
should be reasonably robust in handling deviations from normality. However, it calls 
into question the quality of data analysis in these trials, and their findings should be 
interpreted more cautiously.  
 
Figure 4: Forest plot of comparison 1 - healthcare contacts and resource use 
(continuous data) 
 
 
 
Two trials contributed event-related data to the healthcare contacts and 
resource use outcome, and these were analysed separately (Jensen et al., 2005; 
Siemonsma et al., 2013). The overall effect showed no significant difference 
between groups: OR = 0.75 (95% CI 0.34 to 1.65) z = 0.70, p = 0.48. Heterogeneity 
was moderate, at 58%. 
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Figure 5: Forest plot of comparison 2 - healthcare contacts and resource use 
(dichotomous data) 
 
 
 
Three studies reported that they measured contacts with healthcare 
professionals, but did not provide usable data (de Boer et al., 2014; Nyenhuis et al., 
2013; Schröder et al., 2012). Nyenhuis and colleagues (2013), and Schröder and 
colleagues (2012) reported no significant reduction in healthcare use between 
groups. De Boer and colleagues (2014) reported a marginal difference in costs 
favouring the control group (internet intervention). However, there was a large rate 
of drop-out in the control condition, and the authors reported that the difference was 
“negligible” following the intent to treat analysis.  
3.6.2 Medication use  
Eight trials with usable data contributed to the meta-analysis of medication 
use. Six of these studies reported means and standard deviations (or data that was 
used to derive this information); three referring specifically to mean medication use 
(Martin et al., 2007; Meng et al., 2014; Sleptsova et al., 2013), and three referring to 
the cost of medications (Luciano et al., 2013; McCrone et al., 2012; O'Dowd et al., 
2006). Most of these trials measured actual costs or counts of all medications taken, 
regardless of what they were taken for. One study calculated “days of medication 
use” from participant responses (Martin et al., 2007), and another attempted to 
predict medication usage and associated costs from dichotomous responses using 
an algorithm (O'Dowd et al., 2006). The overall effect showed a small reduction in 
medication use in favour of the intervention: SMD = -0.12 (95% CI -0.24 to -0.00); z 
= 2.04, p = .04. Heterogeneity was low, at 0%.  
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Figure 6: Forest plot of comparison 3 - medication use (continuous data) 
 
 
 
Two trials contributed event-related data to the medication use outcome, and 
this was again analysed separately (Schmidt et al., 2011; Siemonsma et al., 2013). 
Again, the method of measurement of medication use varied. One study measured 
the number of patients in each group taking pain medication (Siemonsma et al., 
2013), whilst the other asked participants to record whether or not they had taken 
“antidepressants, pain killers or sleep medication” (Schmidt et al., 2011). The overall 
effect showed no significant difference between groups: OR = 0.69 (95% CI 0.25 to 
1.91) z = 0.71, p = 0.47. Heterogeneity was moderate, at 33%. 
 
Figure 7: Forest plot of comparison 4 - medication use (dichotomous data) 
 
 
 
3.6.3 Medical investigations 
 
Four trials with usable data contributed to the meta-analysis of medical 
investigations. All of these reported means and standard deviations (or data that 
was used to derive this information); three referring specifically to mean number of 
investigations (Allen et al., 2006; Meng et al., 2014; Sleptsova et al., 2013), and one 
referring to the cost of investigations (Luciano et al., 2013). The overall effect 
showed no significant reduction between groups: SMD = -0.21 (95% CI -0.60 to 
0.17); z = 1.08, p = 0.28. Heterogeneity was high, at 68%. 
. 
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Figure 8: Forest plot of comparison 5 – medical investigations (continuous data) 
 
  
 
4. Discussion 
This review tells three separate but related stories. Firstly, the results of the 
meta-analysis on the effectiveness of CBT-based interventions in reducing 
healthcare consumption are presented. Secondly, these results alongside the risk of 
bias analysis and literature review process give a broader indication of the level and 
quality of the current body of research on medically unexplained symptoms. Finally, 
the conclusions and questions drawn from this review contribute to the on-going, 
wider debate about the clinical usefulness and scientific merits of ‘medically 
unexplained symptoms’ as a diagnostic category.   
4.1 Results of meta-analysis  
16 studies contributed data on the effectiveness of CBT-based interventions in 
reducing healthcare consumption in terms of healthcare contacts (N = 16), 
medication use (N = 8) and medical investigations (N = 4). Of the 5 separate 
analyses of continuous and event-related data in each category, the majority 
showed no effect. The analysis of the effect of treatment on healthcare contacts and 
resource use (continuous data) had a non-significant, but borderline result (p = 
0.06). Likewise, the analysis of medication use (continuous data) resulted in a 
significant, but also borderline effect (p = 0.04). These results are in line with the 
narrative review of the studies that did not provide usable data (N = 3), which 
reported either non-significant or “negligible” reductions in healthcare use. Taken 
together, these findings suggest that CBT-based treatments are not yet delivering 
on promises to reduce healthcare consumption in people with medically unexplained 
symptoms.  
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Heterogeneity was moderate to high in most analyses, but this was expected 
due to the non-standardised and diverse methods of measuring healthcare use 
across studies (for example, the number of visits to a GP versus the cost of a 
consultation). However, despite the methodological differences, the specific 
outcome, particularly in the case of healthcare contacts and resource use, was 
consistent across studies. As a result, and because the scope of this review was to 
specifically address the question of treatment effects on healthcare use, this 
heterogeneity does not have serious implications for the interpretation of results.   
The one exception to this assumption may be in the analyses of medication 
consumption. Although statistical heterogeneity was lower in these analyses, the 
methods of outcome measurement varied in more arbitrary ways and could 
represent a more significant confounding factor in the analysis. As a result, these 
effects should be interpreted more cautiously. It is disappointing that medication use 
was not more robustly measured in some of these studies, or measured at all in half 
of the trials in this review. Reduction in medication use, particularly in opioids for 
pain, is often a target outcome for the treatment of chronic pain (which comprises a 
large proportion of the ‘medically unexplained symptoms’ category), due to concerns 
that long-term use can be a source of harm to patients (Ballantyne, 2015; Standard, 
2013). Likewise, it was also disconcerting that only three studies specifically 
measured medical investigations. Overly intrusive, invasive or unnecessary 
investigations (and associated costs) are also a potential source of harm to patients 
with medically unexplained symptoms (Price, 2008), and risk strengthening the 
illness beliefs that these treatments aim to change.  
Across the studies reviewed as well as those that were excluded, the quality of 
the design and data was often questionable. Data on healthcare use (whether as 
costs, consultations, medications or investigations) should not be difficult to collect 
either through self-report, or through medical or insurance records. The studies that 
incorporated or were followed-up with economic analyses arguably provided the 
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best data, and more studies of this kind are needed. Likewise, it should not be 
overly arduous to ensure that interventions are delivered by suitably qualified 
healthcare professionals, yet a number of trials were excluded from this review for 
that reason. In addition to these findings, there were many concerns with regards to 
size, blinding of outcome assessments, and handling of incomplete data. The lack of 
measurement of treatment expectations across the studies was also an interesting 
finding, particularly given that many theories of medically unexplained symptoms 
emphasise the role of illness belief in the maintenance of symptoms and disability.  
4.2 Status of research on medically unexplained symptoms  
This review is in line with previous Cochrane reviews on medically 
unexplained symptoms, both in finding a small proportion of studies that measured 
healthcare use (Price et al., 2008), and in finding non-significant or borderline 
effects (van Dessel et al., 2014). However, the results presented here were less 
positive than a recent review (Pike et al., 2016) that expanded the search and 
analysis of a Cochrane review on chronic pain (Williams et al., 2012). It could be 
that the treatment protocols and research in the field of chronic pain are more 
developed than they are for the field of medically unexplained symptoms as a 
broader category, and thus the effectiveness of interventions in reducing healthcare 
consumption are greater.   
One of the most telling findings of this review was that, of the 140 studies on 
CBT for medically unexplained symptoms examined in the literature search, half of 
these cited healthcare use as an justification for their research, but 63% of these did 
not go on to measure it as an outcome. Given that a high level of healthcare use is a 
potential indicator of poorly treated symptoms, as well as a major driver of increased 
costs, and a potential source of harm to these patients with medically unexplained 
symptoms, it is surprising that healthcare use is not more universally measured. In 
addition, it is disappointing that more robust and standardised ways of measuring 
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healthcare use are not developed or used in the studies that do report it as an 
outcome.  
4.3 Clinical and research implications 
Due to the broad and overlapping nature of the category of medically 
unexplained symptoms and the difficulties this generates for researchers and 
treatment providers (highlighted in the introduction to this paper), there are many 
limitations and questions raised by this review, and by an examination of the wider 
literature.  
Unfortunately, the more that science answers questions about the aetiology 
and maintenance of specific medically unexplained conditions such as chronic pain, 
the more that health policy and service commissioning seems to focus on lumping 
conditions together under the label of ‘medically unexplained’. This does not reflect 
our best scientific understanding, and introduces non-specificity and potential 
confounding factors in research and clinical practice for these conditions. Using this 
‘diagnosis’ alone, we cannot be confident in either realm that two patients labelled 
with ‘medically unexplained symptoms’ suffer from the same condition or different 
conditions, and we cannot begin to explore what treatments may work best for 
whom, or the specific factors of an intervention that may induce change.  
One of the obvious recommendations from this review is that more studies on 
treatments for medically unexplained symptoms should measure healthcare use as 
an outcome, and that healthcare consumption should be measured in more robust 
and standardised ways. However, it would also be helpful for researchers to unpick 
the factors that contribute to changes in healthcare utilisation. Patients with 
medically unexplained symptoms in particular tend to have difficult relationships with 
healthcare providers, who frequently seem not to believe them or to offer help. As a 
result, there could conceivably be a number of reasons why a patient might consult 
healthcare providers less. Improved knowledge and ability to self-manage 
symptoms could be one explanation, but so could disillusionment with the 
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healthcare system or turning to alternative forms of healthcare. One study in this 
review that found a positive effect of the treatment on healthcare use, reported that 
an element of the intervention was “giving advice about healthcare use” (Martin, 
2007). However, without knowing what message the participants took from this, 
there is no way of knowing if that advice was part of what made the intervention 
successful and the mechanism behind this effect.  
Due to the increasing number of conditions being covered by the label 
‘medically unexplained’, there is a risk that studies were missed from this review and 
in previous reviews. Although the risk for this review in particular was likely reduced 
by building on the search from the van Dessel et al. review (2014), this is a wider 
issue for researchers in this field to consider. As the new DSM-5 diagnoses of 
Somatic Symptom Disorder or Illness Anxiety Disorder no longer have the 
requirement that symptoms be medically unexplained (American Psychiatric 
Association, 2013), it is unclear how future research will incorporate this into 
inclusion criteria in a sensible way (Mayou, 2014; Rief & Martin, 2014; Sharpe, 
2013). Likewise, as our scientific understanding of some medically unexplained 
conditions advances, researchers should be thinking more carefully about how to 
study these conditions, either together or separately, in a more robust and 
meaningful way. 
Although there currently seems to be a drive in policy and service 
commissioning for lumping medically unexplained symptoms together, it is clear that 
more specificity is required to reflect our best scientific knowledge of conditions, and 
design interventions and studies that will tell us more about what treatments work 
best for whom. Otherwise, it is likely that the lack of effect found in this review will 
continue to be found in the future, and this would be a further disservice to people 
suffering with what is currently described as ‘medically unexplained’.   
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The impact of a lack of medical explanation for pain, ‘medically 
unexplained’ comorbid conditions, and ethnicity on CBT therapists’ 
judgments of pain and treatment decisions 
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Abstract 
Background: Judgments of pain are affected by patient and observer factors, 
and this can have an impact on clinicians’ treatment decisions. Aims: To investigate 
the impact of a lack of a medical explanation for pain, ‘medically unexplained’ 
comorbid conditions, and ethnicity on CBT therapists’ judgments of pain and 
treatment decisions. Method: Participants viewed a computer-generated face 
displaying an expression of pain, and a written vignette that presented a brief history 
of the patient. Participants then estimated the severity, exaggeration and 
minimisation of pain, and the likelihood of pain being caused by a mental or physical 
health problem. Participants also ranked a number of treatment options from highest 
priority to lowest priority. Results: Small, but significant effects were found for the 
impact of a lack of a medical explanation for pain and comorbid conditions on CBT 
therapists’ estimations of pain severity and exaggeration. Patients with pain that was 
presented without a medical explanation or who had a comorbid ‘medically 
unexplained’ condition were estimated to be in less pain and more likely to be 
exaggerating their pain. Consistent with those judgments, these patients were also 
more likely to be recommended CBT for depression rather than a referral to a 
specialist service or psychological treatment protocol for pain. Contrary to 
expectations, no effect on pain judgments was found for the variable of ethnicity, but 
ethnicity was found to have an impact on treatment decisions. Participants’ level of 
training was also found to have an impact on treatment decisions. Conclusions: 
The impact of comorbid medically unexplained conditions on pain judgments 
warrants further exploration. Given that recent healthcare initiatives have 
recommended that more people with medically unexplained symptoms be referred 
for psychological interventions, more research on CBT therapists’ pain judgments is 
also needed.  
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1. Introduction 
Explaining and treating the functions and malfunctions of the human body has 
been the perennial task for doctors and scientists since the advent of medicine. 
Over the course of the last century, increasingly advanced tools and methods have 
been developed for exploring and examining the body, and many conditions and 
processes have been explained. However, despite these scientific advances, a 
recent meta-analysis concluded that up to 49% of patients in primary care still 
present with at least one symptom for which no adequate medical explanation is 
found (Haller et al., 2015). For these symptoms, the label ‘medically unexplained 
symptoms’ (MUS) has been increasingly used as a diagnosis (Creed et al., 2010; 
Jutel, 2010; Smith & Dwamena, 2007). This juxtaposition between our high levels of 
medical sophistication and our continued inability to explain some symptoms and 
conditions, has made medically unexplained symptoms and their management a 
contentious issue (Croft, Lewis & Hannaford, 2003; Lynch & Clark, 2005; Merskey, 
2005; Williams & Johnson, 2011; Williamson, Buchanan, Quintner & Cohen, 2005). 
1.1 History 
Prior to the 20th century, most conditions were unexplained and theories about 
disease aetiology varied in their incorporation of psychological elements. Religious 
institutions were often viewed as the custodians of the mind, and many scientists 
and doctors accepted this authority and focused exclusively on the physical body. 
However, other scientists and much of the lay population recognised the impact of 
psychosocial factors on physical functioning. Thomas Wright, a philosopher and 
writer in the early 17th century, theorised that emotional states and thoughts had a 
direct impact on the body (Brown, 1988). Wright and a number of his colleagues 
believed that people could die from broken hearts or extreme fear, and that joy, 
tranquillity and hope could prolong life or effectively treat diseases.  
Over the course of the next 200 years, scientific thinking shifted. This change 
had roots in Cartesian dualism, a philosophy that laid the foundation for thinking 
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about the ‘immaterial’ mind and ‘material’ body as distinct entities (Brown, 1988). 
Although Descartes’ philosophy emphasised the interaction between the mind and 
body, the idea of a ‘mechanical’ body that could be objectively observed and 
measured, gained traction as the scientific tools developed to do so became 
increasingly advanced. Medicine became highly specialised, and scientists favoured 
and focused on anatomical, cellular, biochemical and microbial mechanisms of 
disease.  
By the 20th century, dualistic thinking about the mind and body was firmly 
engrained in scientific thinking. And yet, the phenomenon of interactions between 
mental and physical states remained obvious to many.  The human body did not 
always seem to behave like a machine responding perfectly to inputs, and doctors 
continued to notice the impact of emotions and states of mind on physical outcomes 
(Brown, 1988). It was at this time that the father of psychoanalysis, Sigmund Freud, 
started a movement that would begin to redress this issue through his descriptions 
of mental “neuroses” associated with a multitude of physical symptoms that 
appeared to be generated by those neuroses and cured by talking therapy 
(Nicholson, Stone & Kanaan, 2009). Freud’s theories laid the foundation for the 
study of the mind – psychology – as a scientific discipline.  
Part of this evolution of ideas was the development of ‘psychosomatic 
medicine’, or the study of diseases of the mind that seem to manifest in physical 
symptoms. This began as an extension of Freud’s ideas about neuroses, and 
evolved to encompass all physical symptoms that were deemed to lack an adequate 
medical explanation. Diagnoses were created to describe these conditions such as 
‘Somatization Disorder’, ‘Pain Disorder’ and ‘Conversion Disorder’ (American 
Psychiatric Association, 1994), and terms such as ‘medically unexplained’ and 
‘functional’ symptoms also became more widely used (Brown, 2007; Price, 2008; 
Smith et al., 2007). 
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The benefit of this new field of study was that it reinforced theories about the 
impact that mental states can have on the body. Modern research provides good 
evidence for this notion in general, with clear correlations found between 
psychological factors such as anxiety or depression and poorer outcomes and 
higher levels of disability in people who have suffered from serious health conditions 
such as heart attack (Whooley et al., 2008; Katon et al., 2003) and chronic 
obstructive pulmonary disease (COPD) (Felker et al., 2010). Patients who 
experience health anxiety or panic disorder also demonstrate the powerful impact 
that beliefs and anxiety can have on physical states. However, as our understanding 
of the interactions between mind and body has become more advanced, it has 
become clear that the framework put forward by psychosomatic researchers and 
theorists is too simplistic for many ‘medically unexplained’ conditions.   
For example, the experience of pain was once thought to be only possible in 
the presence of demonstrable tissue damage. However, further research has shown 
that this is not the case. Genuine, often debilitating, chronic pain lasting for longer 
than 3 months and in the absence of observable pathology is a common difficulty 
(Breivik, Collett, Ventafridda, Cohen & Gallacher, 2006). Most patients who 
experience this type of pain would meet diagnostic criteria for a somatic disorder 
(American Psychiatric Association, 1994), and psychosomatic theory posits that this 
pain is the manifestation of suppressed emotions and conflicts (Nemiah et al., 
1976). However, there has been no credible evidence for this theory in relation to 
chronic pain (Crombez et al., 2009; Shattock et al., 2013). In contrast, the well-
established gate-control theory of pain has put forward a credible causal mechanism 
for pain that involves complex interactions between the brain, spinal cord, and 
peripheral nervous system (Melzack & Wall, 1965; Moayedi & Davis, 2013). 
Likewise, a condition such as Chronic Fatigue Syndrome has been widely described 
as medically unexplained, but research has indicated that it is likely to be caused by 
complex interactions between autoimmune, adrenal and psychosocial factors 
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(Hyong et al., 2006).  Thus, psychological factors remain only part of the picture for 
many of these ‘medically unexplained’ conditions, and are not an adequate 
explanation on their own.   
However, despite the lack of evidence, many of the psychosomatic notions 
about medically unexplained symptoms such as chronic pain remain widely believed 
both by the public and healthcare professionals (Crombez et al., 2009; Shattock et 
al., 2013), and are even cited in guidance for both doctors and mental health 
professionals (Commissioning Support for London, 2010; Department of Health, 
2014; Price, 2008). This is perhaps complicated by the fact that we know that stress 
and mental states are associated with levels of disability and prognosis for many 
physical health problems, so it is clear that psychosocial factors are not irrelevant to 
the maintenance and severity of symptoms, whether they are medically explained or 
not. However, this finding does not mean that mental states are the cause of these 
symptoms. A person who has had a heart attack may have been at higher risk due 
to high psychosocial stress and the impact of this on blood pressure, but evidence 
would not support stress alone as a causal mechanism for heart attack.  
However, when symptoms are experienced in the absence of easily 
observable physical abnormalities, even evidence of impaired function seems to be 
discounted by doctors and a ‘mental health’ causal explanation is favoured. This is 
not supported by evidence, and falsely assumes that any symptoms that seem to be 
unexplained must be caused by a mental health problem. A critical reading of the 
scientific literature would suggest that there is still much to learn about the human 
body, and the cause of medically unexplained symptoms and disorders is likely to 
involve complex, multi-system mechanisms.  
1.2 Implications for clinical practice 
Whilst this knowledge is theoretically useful and drives future research, it 
leaves health professionals in a potentially complicated position with patients who 
complain of symptoms for which no simple medical explanation can be offered. 
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Particularly in primary care, doctors have limited time for consultations and 
understandably struggle with patients who present with symptoms for which no 
observable pathology can be found (Chew-Graham et al., 2008, Mathers et al., 
1995; Shattock et al., 2013). For this reason, many guidance documents have been 
produced to help healthcare professionals more quickly diagnose and manage 
people with symptoms that appear to be medically unexplained (Chitnis, Dowrick, 
Byng, Turner & Shiers, 2011; Commissioning Support for London, 2010; Price, 
2008).  
There are a number of benefits associated with quicker identification of people 
with ‘medically unexplained’ conditions or difficulties such as chronic pain (a 
condition that is still described as unexplained, but, as previously highlighted, has a 
well-established causal mechanism). Firstly, these patients could be at an increased 
risk of harm if subjected to overly invasive, costly or unnecessary investigations and 
treatments (Price, 2008). At the very least, these procedures and treatments are a 
potential drain on financial and healthcare resources and offer no clear benefits for 
the patient (Konnopka et al., 2012). At the very worst, unnecessary medical actions 
can have a negative psychological impact on patients or even cause them physical 
harm (Lipsitt et al., 2014). Thus, quicker identification of patients and clear guidance 
on appropriate investigations and treatments could potentially prevent harm to 
patients.  
There has also been growing evidence for the benefit of psychological 
therapies such as Cognitive Behaviour Therapy (CBT) for patients with a variety of 
health conditions, including chronic pain and ‘medically unexplained’ symptoms, as 
well as ‘explained’ conditions such as diabetes and chronic obstructive pulmonary 
disease (Naylor, Parsonage, McDaid, Knapp, Fossey & Galea, 2012; Williams, 
Eccleston, & Morley, 2012). Often this benefit seems to be in relation to addressing 
the psychosocial factors that reduce a patients’ ability to adapt to symptoms and 
increase the risk of disability. Thus, early identification of patients who may benefit 
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from psychological therapy could have significant benefits, and many guidance 
documents recommend referral to mental health services as a first-line treatment 
(Commissioning Support for London, 2010; Department of Health, 2011; 
Department of Health 2014).  
However, there are many disadvantages to these guidance documents as 
well. For example, in their efforts to simplify and expedite clinical decision-making, 
they often use research that shows correlations between ‘medically unexplained’ 
symptoms and factors such as comorbid conditions and high levels of distress and 
disability that seem disproportionate to physical symptoms (Chitnis et al., 2011; 
Department of Health, 2014). However, this implies psychological causal 
mechanisms that are unsupported by research (Crombez et al, 2009; Williams & 
Johnson, 2011).  
It also remains a possibility that some patients with symptoms (including pain) 
that appear to be unexplained, actually have a physical health condition that is 
difficult to diagnose (Smith & Dwamena, 2007). For example, a condition such as 
Rheumatoid Arthritis may be misdiagnosed as a ‘medically unexplained’ condition 
such as a Fibromyalgia, and the resulting delay in treatment could potentially result 
in increased damage to joints (Fitzcharles & Boulos, 2003). Therefore, guidance that 
promotes a quicker diagnosis of medically unexplained symptoms in the absence of 
sufficient medical testing could also be a potential source of harm to patients.    
Finally, in the absence of medical tests for symptoms, healthcare providers 
are effectively being asked to make judgments about the objective severity of 
patients’ symptoms and the appropriate level of associated distress and functional 
impact. These judgments are potentially problematic on a number of levels, and will 
be discussed further in the following section.   
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1.3 Factors that influence pain judgments 
1.3.1 Medical evidence  
Healthcare professionals are frequently required to make judgments about the 
severity of patients’ symptoms, whether explained or unexplained, in order to make 
decisions about symptom management and treatment. For example, a doctor 
seeing a patient with Rheumatoid Arthritis (an autoimmune condition which causes 
joint damage and pain through chronic inflammation) may draw on knowledge from 
research or guidance about the pain caused by the disease, markers of 
inflammation in blood test results, and observable signs of inflammation in joints 
such as swelling, redness and warmth (Siemons et al., 2014). These factors aid 
doctors in making a judgment about the severity of the disease and associated pain, 
which in turn guides them in weighing up the benefits and risks of increased pain 
analgesia or further treatments to reduce levels of inflammation. 
However, in the case of chronic pain and medically unexplained symptoms, 
there are often no observable or measurable markers or changes in the body that 
can be used to inform healthcare professionals’ judgments. In addition, guidance 
documents frequently fail to provide an evidence-based rationale for symptoms such 
as the gate control theory of pain, and advise healthcare professionals to be vigilant 
for levels of distress and disability that seem disproportionate to the severity of 
symptoms (Commissioning Support for London, 2010; Department of Health, 2011; 
Department of Health 2014; Price, 2008, Chitnis et al., 2011). However, in the 
absence of tissue damage or concrete evidence of anything being wrong with a 
patient, and with no framework for understanding how pain can occur under these 
circumstances, any level of distress or disability will likely seem disproportionate to 
the symptoms experienced.  
Given this picture, it is not surprising that healthcare professionals have been 
found to underestimate the severity of pain that is not associated with a medical 
explanation (de Ruddere et al., 2014; de Ruddere, Goubert, Stevens, Williams & 
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Crombez, 2013; de Ruddere, Goubert, Vervoort, Prkachin & Crombez, 2012; Tait & 
Chibnall, 1997; Chibnall, Tait & Ross, 1997), even though this does reflect our best 
understanding of the causal mechanisms and genuine patient experiences of 
chronic pain (Tait, Chibnall & Kalauokalani, 2009).  
Healthcare professionals have also been found to make judgments regarding 
whether pain is being exaggerated or faked by patients (Kappesser, 2006). This 
phenomenon seems to arise from an incorrect assumption that, in the absence of 
verifiable ‘proof’ that pain is real, any expression of pain is likely to be a deviant or 
exaggerated effort to meet some psychological need (Williams, 2002). As a result, 
the people who are tasked with judging pain in others are often concerned with 
“cheater detection”, and ensuring that only those who are deserving receive medical 
treatment and care for pain (Kappesser, 2006).  
However, it has been proposed and demonstrated that people are much more 
likely to suppress or minimise their pain rather than exaggerate it (Williams, 2000). 
This is a recognised clinical problem that is a hindrance to adequate pain 
management. However, the tendency of patients to suppress expressions of pain is 
not a common stereotype, and frequently seems to be overridden by a desire to 
detect malingerers and ensure that healthcare resources are only expended on 
those who ‘deserve’ them. 
1.3.2 Patient factors 
In addition to the lack of medical evidence for chronic pain and medically 
unexplained symptoms as well as the current state of guidance and professional 
knowledge about these conditions, there are many other patient factors that have 
been shown to have an influence, either consciously or unconsciously, on 
healthcare providers’ judgments of symptom severity. This is unlikely to be 
malicious, but rather a genuine effort on the part of the healthcare provider to seek 
further certainty about the severity of symptoms and aid in weighing up the risks and 
benefits of treatment (Tait et al., 2009).  
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Gender 
One patient factor that has been shown to affect pain judgments is gender. 
Multiple studies have found that women are frequently judged to be in less pain than 
their male counterparts (Anderson et al., 2000; Cleeland et al., 1994; Schäfer, 
Prkachin, Kaseweter, Williams, 2016; Tait et al., 2009). This bias has also been 
found to have an impact on treatment decisions, with women receiving less 
analgesia for pain than men (Chang et al., 2007), and being more likely to have their 
pain attributed to psychosocial difficulties (Hoffmann & Tarzian, 2001). This finding 
is perhaps less surprising when guidance on medically unexplained symptoms 
(which tends to incorporate, rightly or wrongly, chronic pain) indicates that the 
diagnosis is more common in women than in men (Chitness et al., 2011; 
Department of Health, 2014). However, it is impossible to know whether this 
correlation is a result or a driver of this bias in pain judgments. Regardless, 
underestimation of the severity of pain based on a lack of medical explanation 
reflects a biased misunderstanding of causal mechanisms and patient experiences 
of chronic pain.  
Ethnicity 
Guidance for healthcare professionals also particularly emphasises a higher 
prevalence of medically unexplained symptoms in people from ethnic minority 
backgrounds (Commissioning Support for London, 2010; Farooq et al., 1995). The 
notion that people from ethnic minority backgrounds tend to experience or 
communicate psychological difficulties through physical symptoms is widely held 
both by the general public and by healthcare professionals. This theory is backed by 
poor quality evidence, and has been challenged by current research (Beirens & 
Fontaine, 2011), but, likely combined with engrained racial biases, it has been 
shown to have a powerful influence on pain judgments and treatment (Anderson et 
al., 2009; Balsa & McGuire, 2003; Hausmann et al., 2013, Tait & Chibnall, 2014). 
For example, in the United States, an extensive study across a variety of settings 
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found that patients from African and Hispanic ethnic backgrounds received lower 
doses of pain medication than their white counterparts with the same conditions 
(Green et al., 2003).  
Comorbidity 
Finally, guidance also suggests to healthcare professionals (including mental 
health practitioners) that a comorbid diagnosis of a mental health problem increases 
the likelihood that a patient’s symptoms will be medically unexplained (Chitness et 
al., 2011, Department of Health, 2014). This recommendation is based on 
epidemiological studies that indicate that depression is commonly comorbid with 
chronic pain and medically unexplained symptoms (Bair et al., 2003; Breivik et al., 
2006; Miller & Cano, 2009). However, there are multiple problems with this 
evidence. Notably, depression is likely to be over diagnosed in patients with chronic 
pain due to overlap between the physical symptoms of depression and the impact of 
pain on physical functioning (e.g. fatigue, difficulties sleeping) and psychological 
wellbeing (Williams, 1998, 2007).  
There is also a longstanding body of research indicating that healthcare 
professionals frequently fail to investigate and treat diagnosable health conditions in 
people with mental health problems (Druss, Rosenheck, Desai, & Perlin, 2002; 
Viron & Stern, 2010). Studies have shown that this is a pervasive failing across 
sectors, from primary care to psychiatric settings. Combined with the impact of 
lifestyle (e.g. increased incidence of smoking) and psychosocial factors on health 
outcomes (e.g. worse outcomes for cardiovascular and pulmonary disease), this 
failure to monitor overall health is likely to be at least partially responsible for 
reduced life expectancy in people with mental health problems (Chesny, Goodwin & 
Fazel, 2014). As a result, it is disconcerting that guidance for health professionals 
frequently encourages them to consider a diagnosis of medically unexplained 
symptoms (and in turn limit medical investigations) in people with comorbid mental 
health problems.  
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Patients with medically unexplained symptoms have been shown to more 
frequently present with a wide range of symptoms and comorbid conditions, and are 
referred to secondary care for further investigations more often than those who have 
symptoms that are medically explained (McGorm et al., 2010). For this reason, 
guidance for healthcare professionals also recommends that symptoms may be 
more likely to be unexplained when they co-occur alongside other symptoms or 
conditions (particularly those that are also deemed to be medically unexplained). 
However, ‘explained’ conditions that affect multiple body systems such as 
Rheumatoid Arthritis also produce a wide array of seemingly unrelated symptoms 
that could be easy to misdiagnose as medically unexplained (Fitzcharles & Boulos, 
2003). Thus, as for people with mental health problems, patients with multiple 
symptoms are also probably at risk of being dismissed, misdiagnosed, or 
ineffectively treated.    
1.4 Impact on patients  
The impact on patients from these frequently biased beliefs about chronic pain 
and medically unexplained symptoms is immense. Not only are their symptoms 
judged to be less serious and potentially under-treated (as highlighted above), but 
research has shown that patients frequently feel disbelieved and dismissed by 
healthcare providers, and this increases their levels of distress (Nettleton, 1982; 
Rhodes et al., 1999; Sim & Madden, 1982; Stone et al., 2002). This is damaging to 
the doctor-patient relationship, and probably increases the risk of inadequate 
symptom management and higher levels of impairment and disability.  
1.6 Implications for psychological therapies 
As stated earlier, there is growing evidence for the effectiveness of psychology 
therapies such as Cognitive Behaviour Therapy (CBT) in the management and 
treatment of people with a number of health problems, including chronic pain and 
medically unexplained symptoms. However, there are a variety of different elements 
associated with CBT treatment protocols, and much is still left to learn in 
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determining which aspects of treatment produce change for whom, and the 
mechanisms that drive these changes (Brown, 2007; Rief & Broadbent, 2007; 
Williams, Eccleston, & Morley, 2012).  
For example, one theory of chronic pain or medically unexplained symptoms 
emphasises the role of unhelpful beliefs in prompting patients to reduce their activity 
levels, which in turn leads to physical deconditioning, increased symptoms such as 
pain and fatigue, and higher levels of functional impairment (Deary, Chalder & 
Sharpe, 2006; Rief & Nanke, 1999). A CBT treatment protocol based on this model 
may exclusively use techniques for challenging unhelpful beliefs (e.g. cognitive 
restructuring, behavioural experiments), or techniques for increasing physical 
activity (e.g. behavioural activation, graded exercise). In comparison, another theory 
emphasises the role of a maladaptation or inflexible response to symptoms, which 
leads to increased levels of distress and increases the likelihood of mood or anxiety 
disorders and higher levels of disability (Yu & McCracken, 2016). Treatment 
protocols based on this model may employ practical problem-solving or coping 
strategies (e.g. pacing of physical activities in order to avoid over-exertion), 
relaxation strategies, or techniques to increase acceptance and adaptation to 
symptoms (e.g. mindfulness, cognitive restructuring).  
However, perhaps due to the relative lack of research showing what works 
best for whom (Williams et al., 2012), there are few available treatment protocols for 
chronic pain that are suitable for utilisation in primary care (Lewis, 2013). Research 
has also shown that there may be a lack of specialist training for CBT therapists and 
psychologists in the treatment of health conditions in general, let alone in the 
comparatively complex area of chronic pain and medically unexplained symptoms 
(Belar et al., 2001; Rozensky, 2014). Perhaps for these reasons, preliminary 
research has shown that primary care CBT therapists in the UK lack knowledge and 
confidence in treating people with medically unexplained symptoms and chronic 
pain (Lewis, 2013). 
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Previous research on healthcare professionals’ judgments of pain severity has 
focused exclusively on medical students, doctors and nurses (de Ruddere et al., 
2014; de Ruddere, Goubert, Stevens, Williams & Crombez, 2013; de Ruddere, 
Goubert, Vervoort, Prkachin & Crombez, 2012; Tait & Chibnall, 1994, 1997). These 
judgments are likely also to be a part of the process with mental health practitioners 
as well, particularly given that they will likely need to assess for whether a patient 
has a mental health problem that would require a particular treatment (e.g. health 
anxiety, depression), or a problem with coping skills and adaptation to symptoms 
that would likely require a different approach.  
However, there seems to be no research that has investigated the pain 
judgments of mental health practitioners, so it is unclear how these may differ (or 
not) from those of medical staff. The majority of CBT therapists and psychologists 
will have a non-medical educational background, and less medical knowledge may 
lead to more biased judgments of pain, particularly when a referral from a medical 
practitioner may provide reassurance that nothing is physical wrong with a patient, 
or that no further medical testing is required. This is particularly the case when, 
rather than psychological therapy being an integrated treatment with the aim of 
helping patients live better with pain from the start, it is offered as a ‘last resort’ 
option when all medical attempts at managing pain have failed. At this late stage in 
the process, there can be a tendency to dismiss pain and focus on the psychosocial 
factors that contribute the experience of pain, and this can leave the patient feeling 
blamed and less amenable to engaging in psychological interventions.  
In addition, given that psychosomatic medicine is a field of psychology, mental 
health practitioners and psychologists may be more familiar with psychosomatic 
theories about ‘medically unexplained’ symptoms and pain. Mental health 
practitioners are also trained to attend more to psychosocial factors and are possibly 
more likely to see difficulties through the lens of mental health. As a result, mental 
health practitioners may be more likely to believe that symptoms without medical 
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explanations are indicators of a mental health problem, and may therefore be more 
likely to disregard or judge physical symptoms to be less serious. These judgments 
could also lead mental health practitioners to choose different treatments for people 
with ‘medically unexplained’ symptoms and pain than they would for people who 
have medical explanations for their symptoms.  
Beyond these practitioner-related factors, there are also patient factors that 
could impact on the effectiveness of psychological therapies for medically 
unexplained symptoms and chronic pain. Patients with ‘medically unexplained’ 
symptoms often fear and feel resentful of having their symptoms disregarded and 
attributed to mental health problems (Sim et al., 1982; Stone et al., 2002), and 
interpret referral to mental health services as an indication of this. Given that these 
difficulties are combined with potential practitioner-related factors (e.g. lack of 
training and treatment protocols for pain and medically unexplained symptoms, 
biased beliefs, and psychosomatic theoretical stance), it is unsurprising that there 
seems to have been limited engagement from patients with chronic pain in 
psychological therapies. 
Governments are understandably keen to reduce the toll of chronic pain and 
medically unexplained symptoms on patients and healthcare resources. In the UK in 
particular, government initiatives have encouraged referral of more people with 
these difficulties to primary care psychological therapies services (Commissioning 
Support for London, 2010; Department of Health, 2011; Department of Health, 2014; 
Rozensky, 2014). However, without addressing the issues raised here, in many 
cases it is unlikely that patients will be effectively treated. Healthcare providers and 
governments aim to have patients engage in and benefit from psychological 
therapies, but this will likely require a certain knowledge, understanding and 
theoretical stance from therapists that many working in primary care are unlikely to 
have at this stage. As a result, the difficulties that are still rampant in medical 
settings are likely to perpetuate in psychological therapies settings as well.  
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1.7 Rationale for current study 
As outlined above, previous studies have investigated the effect of medical 
explanations provided to clinicians and others (or the lack thereof) on their 
judgments of pain, including estimations of pain severity and the likelihood that pain 
is exaggerated or minimised (Chibnall, Tait, & Ross, 1997; de Ruddere et al., 2014, 
2013; Tait & Chibnall, 1994). However, participants in these studies were primarily 
from medical backgrounds. As far as is known, no research of this kind has been 
done with mental health professionals, though the question is particularly relevant in 
light of recent government initiatives aiming to offer psychological therapies as a 
primary treatment for medically unexplained symptoms and chronic pain 
(Commissioning Support for London, 2010; Department of Health, 2011; 
Department of Health, 2014). This is also the case for studies on the impact of 
ethnicity on pain judgments and treatment decisions.  
There also do not appear to be any studies that have investigated the effect of 
information given about comorbid medically unexplained conditions on judgments of 
pain in others.  As previously highlighted, comorbid conditions (and particularly 
those that are considered medically unexplained) have been cited in guidance for 
medical practitioners in identifying and diagnosing medically unexplained symptoms, 
although this recommendation supports a mental health causal mechanism that is 
not supported by science.  
Finally, preliminary research has identified that many primary care CBT 
therapists lack training in understanding or treating medically unexplained 
symptoms or chronic pain, and this is cited as having a potential impact on 
competency (Lewis, 2013; Rozensky, 2014). A lack of training could limit 
practitioners’ understanding of the symptoms of medically unexplained symptoms 
and have an impact on treatment decisions. In turn, this lack of knowledge could 
reduce the effectiveness of psychological therapy for medically unexplained 
symptoms and chronic pain. 
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This study therefore aimed to investigate the factors that impact on mental 
health professionals’ judgments of pain and treatment decisions. The following 
factors were explored: 1) the medical explanation or lack of explanation given for 
pain, 2) the presence or absence of a comorbid medically unexplained condition, 3) 
ethnicity and 4) levels of training in medically unexplained symptoms, chronic pain 
or long-term conditions. The following judgments of pain were also investigated: 1) 
estimates of pain severity, 2) estimates of pain exaggeration, 3) estimates of pain 
minimisation, and 4) estimates of pain being caused by a mental or physical health 
problem.  
2. Research questions and hypotheses 
2.1 Research Question 1: What is the impact of a lack of a medical explanation 
for pain on CBT therapists’ judgments of pain (estimates of pain severity, 
exaggeration and minimisation)? 
Hypotheses: Pain presented without a medical explanation, by contrast with 
pain presented with a common medical explanation, will be estimated by 
participants as: 1a) less severe, 1b) more exaggerated, and 1c) less minimised. 
2.2 Research Question 2: What is the impact of a ‘medically unexplained’ 
comorbidity on CBT therapists’ judgments of pain (estimates of pain severity, 
exaggeration or minimisation, and of the likelihood that pain is caused by 
mental health problem)? 
Hypotheses: Medically explained and unexplained pain that is accompanied 
by a comorbid medically unexplained condition, by contrast with pain with no 
comorbid condition, will be estimated by participants as: 2a) less severe, 2b) more 
exaggerated, 2c) less minimised, and 2d) more likely to be caused by a mental 
health problem. 
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2.3 Research Question 3: What is the impact of ethnicity on CBT therapists’ 
judgments of pain (estimates of pain severity, exaggeration or minimisation, 
and of the likelihood that pain is caused by mental health problem)? 
Hypotheses: Asian patients, by contrast with white patients, will have their 
pain estimated by participants as: 3a) less severe, 3b) more exaggerated, 3c) less 
minimised, and 3d) more likely to be caused by a mental health problem. 
2.4 Research Question 4: Do these variables (ethnicity and the presence or 
absence of a medical explanation for pain or comorbid medically unexplained 
condition) interact to affect CBT therapists’ judgments of pain? 
Hypotheses: There will be interactions between these variables, so that 
medically unexplained pain, accompanied by a comorbid medically unexplained 
condition and experienced by Asian patients, will be estimated by participants as: 
4a) the least severe, 4b) the most exaggerated, 4c) the least minimised, and 4d) the 
most likely to be caused by a mental health problem. 
2.5 Research Question 5: Are CBT therapists’ treatment decisions affected by 
the patient’s ethnicity or the presence or absence of a medical explanation for 
pain or medically unexplained comorbidity?   
Hypotheses:  Participants will prioritise treatment for depression over 
treatment for pain when: 5a) pain is presented without a medical explanation (by 
contrast with pain presented with a common medical explanation), 5b) medically 
explained or unexplained pain is accompanied by a comorbid medically unexplained 
condition (by contrast with pain accompanied by no comorbid condition), and 5c) 
pain is experienced by Asian patients (by contrast with white patients).   
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Research Question 6: Are CBT therapists’ treatment decisions affected by the 
amount of training that they have received in chronic pain, long-term 
conditions, or medically unexplained symptoms? 
Hypothesis: 6a) CBT therapists without training in chronic pain, medically 
unexplained symptoms, or long-term conditions, by contrast with those who have 
had training in these areas, will prioritise treatment for depression over treatment for 
pain.   
3. Method 
3.1 Setting and participants 
This study was conducted using internet-based written vignettes, computer-
generated faces, and questions. Participants were qualified CBT therapists working 
in primary care mental health services in the UK. They were recruited by email 
either directly through their service managers or indirectly through social media and 
emails from CBT education providers. Please see Appendix 10 for a copy of the 
recruitment email, and Appendix 11 for a copy of the online information sheet and 
consent form.  
3.2 Ethics 
Ethical approval was obtained for this study through University College 
London (project ID: 2584/001). For recruitment directly through the National Health 
Service (NHS), sponsorship was obtained through University College London and 
individual approval was granted by nine primary care psychological therapies 
services under six different NHS trusts (West London Mental Health Trust, East 
London NHS Foundation Trust, Central and Northwest London NHS Foundation 
Trust, The Whittington Health NHS Trust, North East London NHS Foundation 
Trust, and Barnet, Enfield and Haringey Mental Health Trust). See Appendices 2 – 9 
for ethical approval letters. 
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3.3 Design 
On accessing the Internet-based study, participants were assigned to see vignettes 
of either Asian or white patients. Participants were then assigned three vignettes 
that included three categories of medical information about the patient:  
1) Chronic pain presented with a common medical explanation and with no 
comorbid conditions (hereafter referred to as “medically explained pain only”) 
2) Chronic pain presented as medically unexplained and with no comorbid 
conditions (hereafter referred to as “medically unexplained pain only”) 
3) Chronic pain presented as either medically explained or unexplained, with a 
comorbid medically unexplained condition, Chronic Fatigue Syndrome 
(hereafter referred to as “comorbid CFS with explained/unexplained pain”).  
A 3 (‘medical information’: medically explained pain only, medically unexplained 
pain only, comorbid CFS with explained/unexplained pain) x 2 (‘ethnicity’: white or 
Asian) mixed design was therefore used. The variable of medical information was a 
within-subjects variable, and the variable of ethnicity was a between-subjects 
variable.  
3.3.1 Survey software and randomisation 
The Qualtrics software (Qualtrics, Provo, UT) was used to host the study on 
the internet and to provide the computerised, automated randomisation. Block 
randomisation procedures were not used. In order to protect participant 
confidentiality, Qualtrics was also configured to ensure that no identifying 
information was gathered from participants.  
3.3.2 Online questions format 
The online questions consisted of two main parts: the experiment proper and a 
survey of specialist training in chronic pain or MUS. The survey was given after the 
experimental questions in order to avoid alerting the participants to the aims of the 
study, and was analysed separately. Appendix 14 shows the internet-based 
questions as they appeared to participants.  
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The first set of dependent variables were related to participants’ judgments of 
pain for each patient: 1) estimates of pain severity, 2) estimates of pain 
exaggeration, 3) estimated of pain minimisation, 4) estimates of the likelihood that 
pain was caused by a mental health problem, and 5) estimates of the likelihood that 
pain was caused by a physical health problem. Responses were given using 
numerical scales from 0 to 10. For pain severity estimates, the scale was anchored 
at 0 with “no pain” and at 10 with “worst possible pain”. For estimates of pain 
exaggeration or minimisation, the scale was anchored at 0 with “no 
exaggeration/minimisation and at 10 with “strong exaggeration/minimisation”. For 
estimates of the likelihood that pain was caused by a mental or physical health 
problem, the scale was anchored at 0 with “very unlikely” and at 10 with “very likely”. 
As previously highlighted, these questions were based on previous research on pain 
judgments.  
The second set of dependent variables was: participants’ decisions regarding 
which treatment options to prioritise (i.e. referral to specialist services for pain, CBT 
for depression, or psychological treatment protocol for pain). These were shown in a 
list format and participants were asked to place them in order of priority. There was 
also an option for participants to indicate that a particular option was unfamiliar to 
them. 
3.3.3 Vignette design and allocation 
Computer-generated patient faces and written vignettes were used to simulate 
the first meeting with a patient experiencing chronic pain and low mood, who was 
either white or Asian, had medically explained or unexplained pain, and either had 
comorbid CFS or no comorbid condition.  
As highlighted in the introduction to this paper, previous research has found 
gender effects on pain judgments, with female patients more likely to have their pain 
underestimated and attributed to a mental health problem. As a result, it was 
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important to control for this factor, and only female patients were used in the 
vignettes for this study. 
The two independent variables (i.e. medical information and ethnicity) were 
manipulated through either the computer-generated faces or written vignettes. 
FaceGen software (Singular Inversions, 2014) was used to produce computer-
generated images of patient faces, and FACSGen 2.0 software (Swiss Centre for 
Affective Sciences, 2010; Roesch et al., 2010) was used to manipulate the 
expressions of these faces. These images began with a photo of an actual person, 
which was then converted into a computer-generated face. This computer-
generated prototype face was then manipulated to express a particular experience 
or emotion, in this case pain. The face could then be replicated, without altering the 
expression, in different genders, ages and ethnicities. For this study, the faces were 
used to manipulate the ethnicity of the person in the vignette, and were also made 
to display facial expressions of pain. Appendix 12 shows the faces and expressions 
that were created for this study.  
The FaceGen and FACSGen software was made available by Dr Eva 
Krumhuber at University College London, who also generated the initial prototype 
faces and pain expressions (along with a research student). Photo editing software 
was then used to add hair and clothing. The pain expressions were also validated 
by Dr Eva Krumhuber (along with a research student), meaning that the expressions 
used in this study were most consistently recognised as expressions of pain. As 
actual photos of white and Asian people were used to create the computer-
generated faces, it was assumed that the faces would also be valid stimuli for the 
variable of ethnicity. However, the ethnicities of the computer-generated faces were 
not validated. Consequently, it is not known whether these faces would be 
consistently recognised as being from the intended ethnic background.   
One advantage of using this technique was that it increased the ecological 
validity of the study by showing patient faces with expressions that indicated the 
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experience of pain, rather than simply a written vignette. Equally, this software 
allowed the same expressions to be used across conditions. In other words, while 
the ethnicity of a patient changed, the facial expression remained the same (Roesch 
et al., 2010). This level of control over facial expressions would not have been 
possible with other commonly used methods, such as the use of actors of different 
ethnicities to portray patients with pain.  
Four different written vignettes and six different computer-generated faces 
were produced. These vignettes and faces were randomly combined using the 
Qualtrics survey software, so that each vignette had an equal chance of being 
paired with each face. This resulted in 32 possible configurations. All vignettes 
showed a female patient presenting at assessment, reporting chronic pain and low 
mood that developed at approximately the same time. The report included either a 
common ‘medical’ explanation for pain (i.e. “slipped disk” or “compressed nerve”) or 
it implied the lack of a medical explanation by reporting that “scans” of the patient’s 
back found “no abnormalities”. The report also included either comorbid CFS or no 
comorbid conditions. Appendix 13 shows the written vignettes that were used for 
this study.  
Of the 32 combinations of written vignettes and faces, each participant was 
allocated to three as follows: on accessing the online questions, participants were 
randomly assigned (using the Qualtrics survey software) either to see patients from 
a white or Asian background. They were then shown one vignette of a patient with 
medically explained pain only, and one with medically unexplained pain only. 
Finally, they were assigned a third vignette of a patient with comorbid CFS that was 
randomly (using Qualtrics) reported alongside either medically explained or 
unexplained pain. 
3.4 Power Analysis 
The power analysis for this study was informed by prior work on judgments of 
pain through the use of vignettes (de Ruddere et al., 2012). This study found a 
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Cohen’s D effect size of 0.5 for pain estimations, which was converted to a F effect 
size of 0.25. The “G*Power 3.1” program (Erdfelder, Faul, & Buchner, 1996) was 
used for the power calculation (alpha, 0.05; desired power, 0.80; estimated 
correlation among repeated measures, 0.5). Due to the mixed within-between 
design used in this study, the required sample size varied. In order to detect effects 
for the within-subjects variable of medical information, 20 participants were required. 
Up to 76 participants were required to detect the effect for the between-subjects 
variable of ethnicity. 
3.5 Analysis 
3.5.1 Pain judgments 
Judgments of pain and the independent variables of medical information and 
ethnicity (and planned contrasts and interactions of these as stated in hypotheses) 
were tested using two-way mixed ANOVAs.  
3.5.2 ANOVA assumptions 
The two-way mixed ANOVA involves three assumptions about study design: 
1) dependent variables are measured at the continuous level (interval or ratio), 2) 
there is one between-subjects, categorical independent variable with at least two 
categories, and 3) there is one within-subjects, categorical independent variable 
with at least two categories (Laerd Statistics, 2015a). Numerical scales, when 
possible answers are formulated symmetrically (i.e. “very unlikely” to “very likely”) as 
they were in this study, can be treated as an interval scale (Carifio & Perla, 2007). 
Therefore, all three of these assumptions regarding study design were met.  
The two-way mixed ANOVA also involves five assumptions about the data 
analysed: 1) no significant outliers, 2) normal distribution, 3) homogeneity of 
variances, 4) homogeneity of covariances, and 5) assumption of sphericity (Laerd 
Statistics, 2015a). It is not uncommon for data to violate one or more of these 
assumptions, so each will be discussed in more detail.    
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All data had some outliers, although none of these were extreme. These 
outliers were always included in the analysis because there was no good reason to 
remove them, and because ANOVAs are considered to be robust to handling 
outliers (Laerd Statistics, 2015a). 
For all variables, the assumption of homogeneity of covariances, as assessed 
by Box's test of equality of covariance matrices (p>.05), was met. For estimations of 
pain severity and exaggeration, the assumption of homogeneity of variances, as 
assessed by Levene’s test (p >.05), was also met. Levene’s test was failed by one 
category of the medical information variable (p = .031) for the analysis of estimates 
of pain minimisation. However, when group sample sizes are approximately equal, 
ANOVAs are considered to be somewhat robust to heterogeneity of variance (Laerd 
Statistics, 2015a). The decision was therefore made to proceed with that analysis.      
As is commonly found in psychological tests using numerical scales, none of 
the data associated with the variable of pain judgments were normally distributed, 
as assessed by the Kolmogorov-Smirnov test (p < .05). All attempts to transform the 
data were unsuccessful. ANOVAs are considered to be robust to deviations from 
normality, particularly in cases where the sample sizes are not small, and the 
groups are similarly skewed (Laerd Statistics, 2015a). Estimates of pain severity 
were all negatively skewed (values ranging from -.576 to -.672), estimates of pain 
exaggeration were all positively skewed (values ranging from 1.144 to 1.684), and 
estimates of pain minimisation were also all positively skewed (values ranging from 
1.024 to 1.418). These variables therefore complied with above guidelines, and the 
associated analyses are considered to be robust.  
In contrast, estimates of the likelihood that pain was caused by a mental or 
physical health problem were not similarly skewed. Estimates of pain being caused 
by a mental health problem were both positively and negatively skewed, with values 
ranging from -.127 to 1.073. Likewise, estimates of the pain being caused by a 
physical health problem had skew values ranging from -.975 to .986. As there were 
82 
 
no non-parametric equivalents to test the two-way mixed interactions, the decision 
was made to proceed with the analysis. However, these results should be 
interpreted with caution.  
Planned interactions between the variables of medical information and 
ethnicity were also tested through two-way mixed ANOVAs. For all variables, the 
assumption of sphericity was met for the two-way interaction, as assessed by 
Mauchly’s test (p>.05).  
3.5.3 Treatment decisions – impact of medical information and ethnicity  
A three-way loglinear analysis was used to determine whether there were any 
associations between the three categorical variables of ethnicity, medical 
information, and participants’ treatment decisions. For this analysis, the hypothesis 
specifically related to whether participants would prioritise treatments for depression 
(i.e. CBT for depression) or pain (i.e. either a referral to specialist services for pain 
or the use of a psychological treatment protocol for pain). The data associated with 
participants’ treatment decisions was converted into a categorical variable with three 
categories: 1) CBT for depression, 2) referral to specialist services for pain, 3) 
psychological treatment protocol for pain. Data associated with all three categorical 
variables was then organised into combined frequencies for each variable category 
and every possible combination of these (shown in Tables 7 and 8).  
In the original design of this study, participants were given five treatment 
options to choose from: 1) CBT treatment for depression, 2) referral to a health 
psychology service, 3) referral to a pain management service, 4) contact GP for 
more information, and 5) psychological treatment for pain. However, when it came 
to analysing these treatment decisions and what they meant for patients, it became 
clear that it was not meaningful in this study to look at the option of contacting the 
GP for more information. Likewise, it was more useful to combine the options of 
health psychology and pain management services, in order to gain a full picture of 
when CBT therapists would prefer to refer to specialist services. It was therefore 
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decided to eliminate the option of contacting the GP and condense the options of 
referral to health psychology and pain management services into one option. This 
reduced the specificity of the analysis, so that it is not possible to determine whether 
CBT therapists preferred to refer to health psychology or pain management 
services. However, as it is not known whether these services were available in 
participants’ areas, that information would have had limited usefulness in this study. 
The purpose of this analysis was to find the simplest model that fit the data. 
Therefore, a hierarchical, unsaturated model was chosen using the SPSS 
hierarchical loglinear model selection procedure, and the backwards elimination 
stepwise procedure (Laerd Statistics, 2015b). This allowed SPSS to remove the 
least statistically significant effects and determine the highest-order effects and main 
interactions (i.e. those that are most predictive of the cell frequencies in the data). 
This process produced a model that included all main effects and two, two-way 
associations between ethnicity and treatment priorities, and medical information and 
treatment priorities. 
Loglinear analysis involves three assumptions: 1) that all cell counts are 
greater than one and 80% are greater than five, 2) there are no outliers, and 3) the 
residuals are approximately normally distributed (Laerd Statistics, 2015b). In this 
analysis, there were 321 responses, with all 18 cells having greater than five 
expected frequencies, no outliers and approximately normally distributed adjusted 
residuals (as assessed by a Q-Q plot).  
3.5.4 Treatment decisions – impact of participants’ level of training 
A chi-square test for association was conducted to determine whether there 
were associations between the two categorical variables of training (i.e. level of 
participants’ training in medically unexplained symptoms, chronic pain, or long-term 
conditions) and treatment decisions. The variable of training had three categories: 1) 
no training, 2) training, duration less than 1 day, 3) training, duration more than 1 
day.  
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As with the previous analysis, data associated with participants’ treatment 
decisions was converted to a categorical form based on the responses given. The 
variable of treatment decisions was again split into three categories: 1) CBT for 
depression, 2) referral to specialist services for pain, 3) psychological treatment 
protocol for pain. Data associated with all three categorical variables was then 
organised into combined frequencies for each variable category and every possible 
combination of these (shown in Table 11).  
The chi-square test for association involves three assumptions: 1) there are 
two categorical variables, 2) there is independence of observations (i.e. groups are 
not related), and 3) all cell frequencies are greater than five (Laerd Statistics, 2016). 
All three of these assumptions were met for this analysis.  
4. Results 
4.1 Participants 
4.1.1 Participant recruitment and attrition rates 
107 participants completed the online questions. A further 32 participants 
either did not complete the questions fully (N = 21), were ineligible to participate due 
to lacking a qualification in CBT (N = 3), or did not provide full consent (N = 8). The 
majority of participants were recruited through social media or emails from CBT 
education providers (N = 91). The remaining participants (N = 48) were recruited 
directly from nine NHS primary care psychological therapy services. The original 
plan for this study was to recruit exclusively from these NHS services, but 
recruitment was much lower than anticipated on the basis of discussions with 
service managers.   
4.1.2 Group allocation 
46 participants were randomly assigned to view three vignettes associated 
with white patients, and 61 to view three vignettes associated with Asian patients. 
After viewing the first two vignettes (one with medically explained pain only and the 
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other with medically unexplained pain only), participants were then randomly 
allocated a third vignette of a patient in the same ethnic group with comorbid CFS 
associated with either medically unexplained pain (N = 56) or medically explained 
pain (N = 51).   
4.1.3 Participant baseline characteristics and survey of training 
In order to preserve the confidentiality of participants, limited information was 
gathered about their ethnic background, educational background, and levels of 
training in chronic pain, MUS or long-term conditions. Tables 1 and 2 provide details 
of the demographic characteristics and training levels of participants.  
The majority of participants were white/white British and described their 
education as non-medical. Most participants reported that they had received some 
amount of training in MUS or chronic pain, although half of these stated that it was 
of 1 day or less duration. Approximately half of these participants reported that they 
had received training in MUS or chronic pain either exclusively or partly through 
their core CBT training.  
 
Table 1. Demographic information for participants 
 n (N = 107)  % 
Ethnicity   
White/White British 88 82 
Asian/Asian British 7  7 
Black/Black British 3  3 
Mixed/Multiple 5  5 
   
Education background   
Non-medical 86 80 
Medical (i.e. nursing) 21 20 
   
Table 2. Training information for participants   
 n (N = 107) % 
Amount of training in medically unexplained conditions, 
long-term conditions or chronic pain   
No training 14 13 
1 day or less of training 46 43 
More than 1 day of training 47 44 
   
Source of training in medically unexplained conditions, 
long-term conditions or chronic pain 
  
Part of core CBT training 31 30 
Additional training 53 51 
Both 20 19 
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4.2 The impact of medical information on pain judgments 
A two-way ANOVA was used to investigate the impact of medical information 
on pain judgments. Sections 3.5.1 and 3.5.2 provide more detailed information on 
the categories of these variables and the fit of the data to the assumptions for 
ANOVAs.  
Table 3 provides the means (standard errors), F ratio, and p values for 
differences between medical information groups for each dependent variable 
associated with pain judgments. Overall, there were significant differences between 
groups for estimations of pain severity (hypotheses 1a and 2a) and exaggeration 
(hypothesis 1b and 2b), but no significant differences between groups for 
estimations of pain minimisation (hypothesis 1c and 2c). In addition, there were 
significant differences between groups for estimations of the likelihood that pain was 
caused by a mental or physical health problem (hypothesis 2d). 
Table 4 shows the mean differences (standard errors), p values, and 95% 
confidence intervals for the pairwise comparisons between conditions. These 
pairwise comparisons were used to answer research questions 1 and 2, and will be 
discussed separately.  
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Table 3. Means (standard errors), F ratios, and p values, for the effect of medical information 
on pain judgments 
 
Medically 
explained 
pain only 
Medically 
unexplained 
pain only 
Comorbid CFS 
with explained/ 
unexplained 
pain  
F 
(2, 
210) 
p 
Questions 
“How severe do you think 
[the patient’s] pain is?” 
Scale from 0 (no pain) to 
10 (worst possible pain) 
 
 
8.3 (1.1) 
 
7.8 (1.4) 
 
7.7 (1.7) 
 
10.02 
 
<.0005 
“How much do you think 
[the patient] is 
exaggerating her pain?” 
Scale from 0 (no 
exaggeration) to 10 (strong 
exaggeration)  
 
2.0 (1.5) 2.7 (2.2) 2.9 (2.3) 14.41 <.0005 
“How much do you think 
[the patient] is minimising 
her pain?”  
Scale from 0 (no 
minimisation) to 10 (strong 
minimisation) 
 
2.6 (2.0) 2.3 (1.9) 2.4 (1.7) 1.36 .260 
“How likely is it that [the 
patient’s] pain is caused by 
a mental health problem?” 
Scale from 0 (very unlikely) 
to 10 (very likely) 
3.6 (2.1) 5.5 (1.9) 5.8 (2.2) 50.96 <.0005 
“How likely is it that [the 
patient’s] pain is caused by 
a physical health 
problem?” Scale from 0 
(very unlikely) to 10 (very 
likely) 
8.7 (1.9) 6.3 (1.7) 6.6 (2.3) 72.12 <.0005 
Note: values in bold denote significance (p < .05) 
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Table 4. Pairwise comparisons (mean difference [standard error], p value, and 95% 
confidence intervals) of the effect of medical information on pain judgments. 
  Mean Difference (standard error) p 
95% Confidence Interval  
Lower       
Bound 
Upper 
Bound 
“How severe do you think [the patient’s] pain is?”  
Scale from 0 (no pain) to 10 (worst possible pain) 
Comorbid CFS 
with explained / 
unexplained pain 
 
Medically 
unexplained pain 
only 
 
-.152 (.158) .340   
Comorbid CFS 
with explained / 
unexplained pain 
 
Medically 
explained pain 
only  
 
-.648 (.153) <.0005 -.952 -.344 
Medically 
unexplained pain 
only 
Medically 
explained pain 
only  
-.496 (.142) .001 -.778 -.214 
“How much do you think [the patient] is exaggerating her pain?”  
Scale from 0 (no exaggeration) to 10 (strong exaggeration)  
Comorbid CFS 
with explained / 
unexplained pain 
 
Medically 
unexplained pain 
only 
 
.207 (.193) .287   
Comorbid CFS 
with explained / 
unexplained pain 
 
Medically 
explained pain 
only 
 
.931 (.181) <.0005 .573 1.290 
Medically 
unexplained pain 
only 
Medically 
explained pain 
only 
.725 (.172) <.0005 .384 1.065 
“How likely is it that [the patient’s] pain is caused by a mental health problem?” 
Scale from 0 (very unlikely) to 10 (very likely) 
Comorbid CFS 
with explained / 
unexplained pain 
 
Medically 
unexplained pain 
only 
 
.275 (.245) .265   
Comorbid CFS 
with explained / 
unexplained pain 
 
Medically 
explained pain 
only 
 
2.266 (.273) <.0005 1.725 2.807 
Medically 
unexplained pain 
only 
Medically 
explained pain 
only 
1.991 (.213) <.0005 1.568 2.414 
“How likely is it that [the patient’s] pain is caused by a physical health problem?”  
Scale from 0 (very unlikely) to 10 (very likely) 
Comorbid CFS 
with explained / 
unexplained pain 
 
Medically 
unexplained pain 
only 
 
-.383 (.275) .168   
Comorbid CFS 
with explained / 
unexplained pain 
 
Medically 
explained pain 
only 
 
-2.104 (.276) <.0005 -2.651 -1.557 
Medically 
unexplained pain 
only 
Medically 
explained pain 
only 
-2.487 (.215) <.0005 -2.912 -2.061 
Note: values in bold denote significance (p < .05) 
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Research Question 1: What is the impact of a lack of a medical explanation for 
pain on CBT therapists’ estimations of pain severity, and estimations of the 
likelihood that pain is exaggerated or minimised? 
Overall, estimates of the severity of patients’ pain were high across 
categories. However, pain that was presented with a common medical explanation 
was estimated as significantly more severe than medically unexplained pain (mean 
difference = 0.496, p = .001, d = 0.402 [medium effect]) (Cohen, 1992). This means 
that, on average, pain presented as medically unexplained was estimated to be half 
a point less severe on a scale from 0 (no pain) – 10 (worst possible pain) than pain 
that was presented with a common medical explanation (hypothesis 1a).  
Likewise, medically explained pain was estimated to be significantly less 
exaggerated than medically unexplained pain (mean difference = -.725, p < .0005, 
d = - 0.383 (medium effect), although ratings overall were low (hypothesis 2a).   
Medically unexplained pain was also estimated to be significantly more likely 
to be caused by mental health problem and significantly less likely to be caused by 
a physical health problem than medically explained pain.  
4.3 Impact of comorbidity on pain judgments 
Research Question 2: What is the impact of a medically unexplained comorbid 
condition on CBT therapists’ estimates of pain severity, exaggeration or 
minimisation, and estimations of the likelihood that pain is caused by mental 
health problem? 
When compared with medically explained pain only, both explained and 
unexplained pain were estimated to be less severe when accompanied by comorbid 
CFS (mean difference = -.648, p < .0005), d = -0.438 [medium effect]) (hypothesis 
2a). This difference in estimates of pain severity was similar to the previous 
analysis, meaning that pain accompanied by comorbid CFS as well as pain 
presented without a medical explanation were judged to be similarly less severe (by 
about half a point on a scale from 0 (no pain) – 10 (worst possible pain) than pain 
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that was presented with a common medical explanation and no comorbid 
conditions.  
Both explained and unexplained pain were also estimated to be more 
exaggerated when accompanied by comorbid CFS (mean difference = .931, p 
<.0005, d = 0.466 [medium effect]) (hypothesis 2b). This was a higher difference 
than the previous analysis, with pain accompanied by comorbid CFS being judged 
as more exaggerated by nearly 1 point higher on a scale from 0 (no exaggeration) to 
10 (strong exaggeration) than pain that was presented with a common medical 
explanation and no comorbid conditions.  
In addition, explained or unexplained pain that was accompanied by a MUS 
comorbid condition was estimated to be significantly more likely to be caused by a 
mental health problem (mean difference = 2.266, p <.0005, d = 1.034 [large effect]), 
and significantly less likely to be caused by a physical health problem (mean 
difference = -2.104, p <.0005, d = -1.024 [large effect]) (hypothesis 2d). This was a 
strong effect, with over a 2 point difference in scores on a scale from 0 (very 
unlikely) to 10 (very likely).  
Although not a significant difference, the directions of effects were the same 
when explained/unexplained pain with comorbid CFS was compared with medically 
unexplained pain only (Table 4).  
4.4 Impact of ethnicity on pain judgments 
Research Question 3: What is the impact of ethnicity on CBT therapists’ 
estimations of pain severity, exaggeration or minimisation, and estimations of 
the likelihood that pain is caused by mental health problem? 
There was no significant effect of ethnicity on estimations of pain severity 
(hypothesis 2a), exaggeration of pain (hypothesis 2b), or minimisation of pain 
(hypothesis 2c), or on the estimations of the likelihood that pain was caused by a 
mental or physical health problem (hypothesis 2d). Table 5 provides the means 
(standard errors), F ratios, and p values for these differences.   
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In line with the previous findings, the mean estimates of pain severity were 
high, and mean estimates of pain exaggeration and minimisation were low. Although 
there were no significant differences, there was a trend (in line with hypotheses) for 
White patients, in contrast with Asian patients, to have their pain estimated as more 
severe (mean difference = 0.2), less exaggerated (mean difference = -0.1), more 
minimised (mean difference = 0.3), more likely to be caused by a mental health 
problem (mean difference = 0.4), and less likely to be caused by a physical health 
problem (mean difference = 0.2). 
 
Table 5. Means (standard errors), F ratios, and p values, for the effect of ethnicity on pain 
judgments 
    Asian patients White patients 
F 
(1, 
105) 
p 
Questions 
“How severe do you think [the 
patient’s] pain is?” 
Scale from 0 (no pain) to 10 (worst 
possible pain) 
 
 
   7.8 (0.1) 
 
8.0 (0.2) 
 
.693 
 
.407 
“How much do you think [the 
patient] is exaggerating her pain?” 
Scale from 0 (no exaggeration) to 
10 (strong exaggeration)  
 
   2.5 (0.2) 2.6 (0.3) .307 .581 
“How much do you think [the 
patient] is minimising her pain?”  
Scale from 0 (no minimisation) to 
10 (strong minimisation) 
 
   2.3 (0.2) 2.6 (0.2) 1.066 .304 
“How likely is it that [the patient’s] 
pain is caused by a mental health 
problem?” 
Scale from 0 (very unlikely) to 10 
(very likely) 
 
   4.8 (0.2) 5.2 (0.2) 1.341 .249 
“How likely is it that [the patient’s] 
pain is caused by a physical 
health problem?” Scale from 0 
(very unlikely) to 10 (very likely) 
   7.3 (0.2) 7.1 (0.2) .543 .463 
Note: values in bold denote significance (p < .05) 
 
 
 
 
 
92 
 
4.5 Impact of interactions between variables on pain judgments 
Research Question 4: Do the variables of medical information (medically 
unexplained pain with no comorbidity, medically explained pain with no 
comorbidity, explained/unexplained pain with a comorbid MUS condition) and 
ethnicity interact to affect CBT therapists’ judgments of pain? 
There was no significant effect from the interaction between medical 
information and ethnicity on CBT therapists’ judgments of pain (Table 6).  
 
Table 6. Interactions between medical information and ethnicity on pain estimations 
 Medical Information x Ethnicity 
 F (2, 104) p 
Estimations of pain severity .969 .383 
.608 
.362 
.406 
.056 
  
Estimations of pain exaggeration  .500 
Estimations of pain minimisation 1.132 
Pain caused by mental health problem  .905 
Pain caused by physical health problem 2.958 
Note: values in bold denote significance (p < .05) 
 
 
4.6 Impact of medical information and ethnicity on treatment decisions 
Research Question 5: Are CBT therapists’ treatment decisions affected by the 
variables of medical information and ethnicity?  
A three-way loglinear analysis was used to determine whether there were any 
associations between the variables of ethnicity, medical information, and 
participants’ treatment decisions. Section 3.5.4 provides more detailed information 
on the categories of these variables and the fit of the data to the assumptions for 
loglinear analysis.  
The loglinear analysis produced a model that included all main effects and 
two, two-way associations between ethnicity and treatment priorities, and medical 
information and treatment priorities. The Pearson goodness-of-fit test indicated that 
the model was a good fit to the observed data, χ2(6) = 0.588, p = .997.  
Total cell frequencies for each variable are shown in Table 7, and cell 
frequencies for all possible interactions of variables are shown in Table 8. Overall, 
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participants did not prioritise CBT for depression over specialist referral or specific 
psychological treatment protocols for pain (hypothesis 5a). Rather, most participants 
(72.6%) prioritised referrals to specialist services or psychological treatment 
protocols for pain.  
 
Table 7. Total cell frequencies and percentages (out of the overall responses in each 
category) of participants’ treatment decisions by the variables of ethnicity and medical 
information  
Variable / Combination                       Treatment Decision Frequency % 
Overall CBT for depression  88 27.4 
Referral to specialist for pain  124 38.6 
Psychological treatment protocol for 
pain 
109 34.0 
Ethnicity = white  CBT for depression  50 36.2 
Referral to specialist for pain  48 34.9 
Psychological treatment protocol for 
pain 
40 28.9 
Ethnicity = Asian  CBT for depression  38 20.8 
Referral to specialist for pain  76 41.5 
Psychological treatment protocol for 
pain 
69 37.7 
Medical information = 
medically unexplained pain 
only  
CBT for depression  36 33.6 
Referral to specialist for pain  37 34.6 
Psychological treatment protocol for 
pain 
34 31.8 
Medical information = 
medically explained pain only  
CBT for depression  18 16.8 
Referral to specialist for pain  48 44.6 
Psychological treatment protocol for 
pain 
41 38.3 
Medical information = 
comorbid CFS with 
explained/unexplained pain 
CBT for depression  34 31.8 
Referral to specialist for pain  39 36.4 
Psychological treatment protocol for 
pain 
34 31.8 
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Table 8. Cell frequencies and percentages (of overall responses) of participants’ treatment 
decisions by the variables of ethnicity and medical information, as well as interactions of 
these variables 
Variable / Combination                       Treatment Decision Frequency % 
[ethnicity = white] x [medical 
Information = medically 
unexplained pain only] 
CBT for depression  21 6.5 
Referral to specialist for pain  13 4.0 
Psychological treatment protocol for 
pain 
12 3.7 
[ethnicity = white] x [medical 
information = medically 
explained pain only] 
CBT for depression  10 3.1 
Referral to specialist for pain  20 6.2 
Psychological treatment protocol for 
pain 
16 5.0 
[ethnicity = white] x [medical 
information = comorbid CFS 
with explained/unexplained 
pain] 
CBT for depression  19 5.9 
Referral to specialist for pain  15 4.7 
Psychological treatment protocol for 
pain 
12 3.7 
[ethnicity = Asian] x [medical 
Information = medically 
unexplained pain only] 
CBT for depression  15 4.7 
Referral to specialist for pain  24 7.5 
Psychological treatment protocol for 
pain 
22 6.9 
[ethnicity = Asian] x [medical 
Information = medically 
explained pain only] 
CBT for depression  8 2.5 
Referral to specialist for pain  28 8.7 
Psychological treatment protocol for 
pain 
25 7.8 
[ethnicity = Asian] 
x [medical information = 
comorbid CFS with 
explained/unexplained pain] 
CBT for depression  15 4.7 
Referral to specialist for pain  24 7.5 
Psychological treatment protocol for 
pain 
22 6.9 
 
Although most participants preferred specialist referrals or psychological 
treatment protocols for pain, there were significant associations between ethnicity 
and treatment decisions (hypothesis 5c), as well as between medical information 
and treatment decisions (hypotheses 5a and 5b). Table 9 shows the partial 
likelihood ratios χ2 (i.e. associations), degrees of freedom, and p values for the 
interactions between these variables. Table 10 shows the parameter estimates, Z 
scores and p values for the specific interactions that were the most predictive of cell 
frequencies.  
In contrast with the hypothesis (5c), participants preferred CBT for depression 
significantly more for white patients than for Asian patients (λ = .734, p = .002) 
(Table 10). 36.2% of participants’ prioritised treatment for depression for white 
patients, as opposed to 20.8% of participants who prioritised treatment for 
depression for Asian patients (Table 7).  
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In line with the hypotheses (5a and 5b), CBT for depression was the least 
preferred treatment option for patients with medically explained pain only (λ = -.844, 
p = .020) (Table 10). This means that treatment for depression was prioritised by 
more participants for patients with medically unexplained pain only and 
explained/unexplained pain accompanied by comorbid CFS (33.6% and 31.8% of 
participants respectively), than it was for patients with medically explained pain only 
(16.8% of participants).  
 
Table 9. Partial associations, degrees of freedom, and p values for the interactions between 
the variables of ethnicity, medical information and treatment decisions  
Variables Partial Association χ2 Degrees of Freedom p 
Interaction between ethnicity and 
treatment decisions 
 
9.782 
 
2 
 
.008 
Interaction between medical 
information and treatment decisions 
 
9.995 
 
4 
 
.041 
Note: values in bold denote significance (p < .05) 
 
 
Table 10. Parameter estimates, Z scores and p values for the hierarchical model: interaction 
between ethnicity and treatment decisions, and interaction between medical information and 
decisions 
Parameter Estimate 
(standard 
error) 
Z p 
Interaction: [ethnicity = white] x [treatment priority 
= CBT for depression] 
.734 (.283) 3.056 .002 
 
Interaction: [medical information = medically 
explained pain only] x [treatment priority = CBT for 
depression] 
-.844 (.363) -2.327 .020 
Note. Z = Estimate (λ) / Standard Error; values in bold denote significance (p < .05) 
 
 
4.7 Impact of training on treatment decisions 
Research Question 6: Are CBT therapists’ treatment decisions affected by the 
level of training that they have received in chronic pain, long-term conditions, 
or medically unexplained symptoms? 
A chi-square test for association was conducted to determine whether there 
were associations between the two categorical variables of training (i.e. level of 
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participants’ training in medically unexplained symptoms, chronic pain, or long-term 
conditions) and treatment decisions. Section 3.5.5 provides more detailed 
information on the categories of these variables and the fit of the data to the 
assumptions for the chi-square test.  
10% of participants (N = 14) stated that they had no specialist training in 
treating MUS, chronic pain or long-term conditions, and 8% (N = 9) responded to 
indicate that they were had no knowledge of specific treatment protocols for pain or 
MUS. The remaining participants (N = 93) reported that they had received some 
training in treating MUS, chronic pain or long-term conditions, but half of these (N = 
46) reported they had only received 1 day or less of training. 
Cell frequencies for each variable are shown in Table 11. 
 
Table 11. Cell frequencies and percentages of participants’ treatment decisions by the 
variable of training 
Variable / Combination                       Treatment Decision Frequency % 
Overall CBT for depression  88 27.4 
 Referral to specialist for pain Psychological treatment protocol for pain  
124 
109 
38.6 
34.0 
Training = no training CBT for depression  6 14.3 
 Referral to specialist for pain Psychological treatment protocol for pain  
29 
7 
69.0 
16.7 
 
Training = training, 
duration less than 1 day 
CBT for depression  40 29.0 
Referral to specialist for pain 
Psychological treatment protocol for pain  
50 
48 
36.2 
34.8 
 
Training = training, 
duration more than 1 day 
 
CBT for depression  42 29.8 
Referral to specialist for pain 
Psychological treatment protocol for pain  
45 
54 
31.9 
38.3 
 
 
There was a statistically significant association between training and treatment 
preferences, χ2(4) = 19.473, p = .001. There was also a moderately strong 
association between participants’ level of training (i.e. no training, training of 
duration less than one day, and training of duration more than one day) and their 
treatment preferences, φ = 0.174, p = .001. Participants with no training, rather than 
preferring CBT for depression as hypothesised (hypothesis 6a), actually had a 
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strong preference for referring patients on to specialist services for pain (Figure 5). 
As the duration of training increased, so also did participants’ preference for the use 
of CBT treatment protocols for pain.  
 
 
Figure 4. Percentages of participants in each training category who preferred CBT for 
depression, specialist referral, or specific treatment protocols for pain 
 
 
 
 
5. Discussion 
This study investigated the effects of three variables on CBT therapists’ 
judgments of pain and treatment decisions for patients with chronic pain. The first 
variable of interest in this study was the medical information given about a patient: 
whether their pain was presented as medically explained or unexplained, and 
whether their pain (explained or unexplained) was accompanied by a comorbid 
medically unexplained condition (CFS) or not. The second variable was the patient’s 
ethnicity (white or Asian). Finally, the third variable was participants’ levels of 
training in medically unexplained symptoms, long-term conditions, or chronic pain. 
5.1 The impact of a lack of medical explanation on CBT therapists’ judgments of 
pain and treatment decisions 
The presence or absence of a medical explanation for pain was one of the 
main variables of interest in this study, and three of the four hypotheses related to 
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this variable (hypotheses 1a, 1b, 5a) were supported. Estimates of pain severity 
were overall high. However, patients with pain that was presented with a common 
medical explanation were consistently estimated to be in more severe pain than 
patients whose pain was presented as medically unexplained. Although this 
difference was associated with a medium effect size, the actual difference was 
small, at about half a point on a 0 – 10 scale. Thus, this was a small, but significant 
result.  
Although estimates were low overall, patients with medically unexplained pain 
were also judged to be significantly more likely to be exaggerating their pain. This 
difference was slightly bigger than for pain severity estimates, at nearly three 
quarters of a point on a 0 – 10 scale, but it was still a small difference.   
As hypothesised, CBT therapists were also more likely to prefer treatment for 
depression for patients whose pain was presented as medically unexplained. 33.6% 
of participants preferred treatment for depression for patients with medically 
unexplained pain, as opposed to 16.8% of participants who preferred CBT for 
depression for patients with pain presented with a common medical explanation.  
These findings are in line with previous studies that have found that healthcare 
professionals frequently underestimate the severity of pain when it lacks a medical 
explanation (de Ruddere et al., 2014; de Ruddere, Goubert, Stevens, Williams & 
Crombez, 2013; de Ruddere, Goubert, Vervoort, Prkachin & Crombez, 2012; Tait & 
Chibnall, 1994). As previously highlighted, the genuine experience of chronic pain is 
not dependent on observable evidence of tissue damage or physical pathology. As 
a result, there is no scientific basis for even a small difference in pain judgments and 
resulting treatment decisions, based on the lack of a medical explanation for pain.  
Although participants in general prioritised specific treatment protocols or 
specialist referrals for patients with pain, in light of the above, it is disconcerting that 
they preferred CBT for depression significantly more when pain was presented 
without a common medical explanation. One possible explanation is that 
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participants lacked knowledge of the credible causal mechanisms for chronic pain, 
or were influenced by outdated psychosomatic theories of pain, and this possibility 
will be discussed further in section 5.4. Alternatively, they could have been 
influenced by beliefs related to the authenticity of symptoms that are deemed to be 
medically unexplained, and this possibility will be explored more in section 5.2. 
5.1.1 Pain minimisation 
All hypotheses related to estimates of pain minimisation (hypotheses 1c, 2c 
and 3c) were unsupported by this study. As previously highlighted, and in contrast 
with popular stereotypes, patients with chronic pain frequently tend to hide or 
minimise their pain. As a result, it is a clinical problem that is often overlooked. This 
is consistent with the findings of this study, in which estimates of pain minimisation 
were very low and no significant differences were found between groups. This 
indicates that many of the CBT therapists who participated in this study probably 
lacked more in-depth knowledge of chronic pain and how it presents clinically.   
5.2 The impact of a comorbid medically unexplained condition on CBT therapists’ 
judgments of pain and treatment decisions 
Comorbidity with a condition that is commonly described as medically 
unexplained, CFS, was also a primary variable of interest in this study. Again, four 
of the five hypotheses related to this variable (hypotheses 2a, 2b, 2d, 5b) were 
supported. Patients who were reported to have CFS and pain, regardless of whether 
or not their pain was presented as explained or unexplained, were consistently 
judged to be in less pain than patients with medically explained pain and no 
comorbid CFS. Patients with CFS were also judged to be significantly more likely to 
be exaggerating their pain. As with the previous variable, the actual difference in 
these ratings were fairly small, at about half to three-quarters of a point on a 0 to 10 
scale.    
In addition, patients with CFS were significantly more likely to have their pain, 
whether it was associated with a medical explanation or not, judged to be caused by 
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a mental health problem. This result was associated with a large effect size, and the 
actual difference was also large, at just over 2 points on a 0 to 10 scale. The mean 
rating for pain associated with comorbid CFS being caused by a mental health 
problem was nearly 6/10 (meaning fairly likely), whereas the mean rating for 
medically explained pain only was about 3.5/10 (meaning fairly unlikely). This was 
the largest difference found in this study.  
As would be expected from these judgments, CBT therapists were also more 
likely to prefer CBT for depression for patients with CFS, regardless of whether their 
pain was explained or unexplained. This difference was even slightly more than for 
patients with medically unexplained pain only, with 33.6% of participants preferring 
treatment for depression for patients with comorbid CFS, as opposed to 16.8% of 
participants who preferred treatment for depression for patients with explained pain 
without comorbid CFS.  
The potential implications of these findings for patients with CFS (and possibly 
other conditions currently described as medically unexplained) are substantial. 
These results show that the same patient referred for chronic pain could potentially 
have a very different treatment experience and working diagnosis (i.e. depression or 
difficulty adjusting to a physical health condition), not based on information about 
their pain or mood, but on whether or not the CBT therapist is made aware of their 
CFS diagnosis and holds certain biases about the mechanisms of chronic pain and 
medically unexplained symptoms. This result is troubling on a number of levels.  
There is some overlapping symptomatology between depression and CFS, the 
primary symptom being fatigue/lack of energy, but also disturbed sleep, difficulties 
concentrating and making decisions (“brain fog”), and low mood (American 
Psychiatric Association, 2014; World Health Organization, 1992). However, CFS is 
not in the diagnostic criteria for depression, and at most it should be a part of a 
formulation rather than a critical factor in decisions regarding a working diagnosis or 
appropriate treatment options. In actuality, people with CFS are probably at risk of 
 101 
 
overdiagnosis of depression because of the overlapping symptoms, particularly 
when their mood is impacted by their inability to engage in activities they enjoy due 
to severe and persistent fatigue. In addition, despite often being described as 
medically unexplained, CFS is a condition that has been found to be associated with 
adrenal, autoimmune, and psychosocial factors (Hyong et al., 2006). Thus, 
diagnosing and treating a patient for depression rather than chronic pain, simply 
based on their additional diagnosis of CFS, would be a misguided and potentially 
harmful decision.  
These findings are line with previous research that has highlighted healthcare 
providers’ beliefs that patients with medically unexplained symptoms tend to be 
manipulative and exaggerate their symptoms, or that medically unexplained 
symptoms are the result of mental health problems (Shattock et al., 2013). Likewise, 
these results provide some evidence for patients’ perceived stigma associated with 
a CFS. People with CFS and other conditions described as medically unexplained 
have reported that they feel disbelieved by health professionals, and that their 
symptoms are judged to be illegitimate, fabricated, or caused by a mental health 
problem (Sim & Madden, 2008; Stone et al., 2002). This study corroborates those 
fears.   
5.3 The impact of ethnicity on CBT therapists’ judgments of pain and treatment 
decisions, and the interaction between the variables of ethnicity and medical 
information 
This study also aimed to investigate the impact of ethnicity on CBT therapists’ 
judgments of pain and treatment decisions. However, all five hypotheses related to 
this variable were unsupported (hypotheses 3a, 3b, 3c, 3d, 5c). Although pain 
judgments for white and Asian patients showed differences that were in line with the 
hypotheses, these were not significant. There was also no significant interaction 
found between the variables of ethnicity and medical information. 
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The one significant result that was found for the variable of ethnicity was 
actually in direct contrast with what was hypothesised (5c). This was the finding that 
treatment for depression was preferred by significantly more participants for white 
patients rather than Asian patients. This was a significant difference, with 36.2% of 
participants’ prioritising treatment for depression for white patients, as opposed to 
20.8% of participants prioritising treatment for depression for Asian patients.  
These findings are at odds with a longstanding body of research that has 
found significant effects on pain judgments and treatment decisions for patients from 
ethnic minority backgrounds. Previous studies have consistently shown that patients 
from ethnic minority backgrounds tend to have their pain underestimated, and this 
has a negative impact on their treatment and the management of their symptoms 
(Anderson et al., 2009; Balsa & McGuire, 2003; Green et al., 2009; Hausmann et 
al., 2013, Tait & Chibnall, 2014).  
As a result, the absence of significant differences in pain judgments between 
ethnic groups is difficult to interpret. It could be that, with time, the unconscious 
biases demonstrated by research are having less of an influence over healthcare 
providers’ judgments of pain in general, or that CBT therapists in the ethnically 
diverse area of London are less susceptible to these biases. Alternatively, it may be 
something about the computer-generated faces or design used in this study (i.e. 
participants being allocated to see all white or all Asian patients) that either allowed 
participants to guess the purpose of the study, or did not emphasise the ethnicity of 
the patient enough to trigger unconscious racial biases. Another study that used 
vignettes to test racial disparities in pain judgments also failed to find typical effects, 
and hypothesised that this type of stimulus does not capture essential aspects of the 
clinical experience, such as poor doctor-patient rapport and stigmatising behaviours 
(Burgess et al., 2008). However, if any of these possible explanations were wholly 
accurate, no variables would be expected to show significant differences between 
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ethnic groups, when in fact one significant difference in treatment decisions was 
found.  
The finding that CBT for depression (the treatment option that is considered 
the least appropriate for all patients in this study) was significantly more preferred 
for white patients is puzzling. Although this finding could mean that Asian patients 
referred with chronic pain are more likely to receive an appropriate treatment for 
chronic pain, it may also indicate that it would be difficult for Asian people to access 
psychological treatments for mental health problems in primary care.  
There are a number of possible explanations for this difference in treatment 
preferences, all of which are open to speculation. For example, it may be that 
participants believed that Asian patients would not be amenable to psychological 
therapy for a mental health problem. This belief would be in line with some literature 
that suggests it can be difficult to engage Asian patients in psychological treatments, 
although there are a number of potential reasons for this, and the difficulty is likely to 
be as much on the part of practitioners as it is for patients. Alternatively, it could be 
due to an unconscious bias against working with Asian patients, resulting in a higher 
preference for onward referral.  These possible explanations are equally likely, as 
41.5% of participants preferred onward referrals to specialist services for pain for 
Asian patients (as opposed to 34.9% for white patients), and 37.7% of participants 
preferred a psychological treatment protocol for pain for Asian patients (as opposed 
to 28.9% for white patients).  
On the other hand, it is encouraging that CBT therapists did not appear to 
have a bias against referring Asian patients to specialist services for difficulties 
related to CFS or chronic pain. It has often been reported that ethnic minorities are 
underrepresented in specialist services for pain (Green et al., 2003). These results 
could indicate that CBT therapists are better at recognising people from ethnic 
minority backgrounds with difficulties that would benefit from referral to specialist 
services for chronic pain. 
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5.4 The impact of CBT therapists’ levels of training on treatment decisions 
Finally, this study investigated the impact of training in chronic pain, MUS, or 
long-term conditions on CBT therapists’ treatment decisions. Overall, CBT 
therapists showed a strong preference across groups for treatment for pain (e.g. 
referrals to specialist services or psychological treatment protocols for pain) over 
treatment for depression. A statistically significant association was also found 
between participants’ level of training and treatment decisions. However, this was 
not in the way expected. In contrast with the hypothesis (6a) that participants with 
no training would prefer CBT for depression, they actually showed a strong 
preference for referring patients on to specialist services for pain. It was also found 
that CBT therapists who reported having received more training also showed a 
stronger preference for the use of specific treatment protocols for pain.  
In addition, 87% of participants reported that they had received at least some 
training in MUS, chronic pain or long-term conditions, and half of these said that 
they had received more than 1 day of training. Only 13% of participants stated that 
they had received no training, and just 8% responded to indicate that they had no 
knowledge of specific treatment protocols for pain.  
These results are very encouraging, and are in contrast with some preliminary 
research that indicated that few treatment manuals are available for working with 
medically unexplained symptoms and chronic pain, and that many primary care CBT 
therapists feel less competent in treating these conditions (Lewis, 2013). However, 
these results are also inconsistent with the troubling finding (discussed in sections 
5.1 and 5.2) that CBT for depression was preferred for patients with medically 
unexplained pain and comorbid CFS. Together, these findings suggest that, while 
the overall picture of primary care CBT therapists’ training and treatment decisions 
with regards to pain is promising, there are likely to be persistent unconscious 
biases that impact on how CBT therapists conceptualise and treat pain for patients 
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from ethnic minority backgrounds, as well as patients with medically unexplained 
symptoms.  
5.5 Study limitations 
This study has a number of limitations that may have had an impact on the 
accuracy of the results. Firstly, the computer-generated images of patient faces may 
not have been a sufficient prompt to trigger biases related to the patient’s ethnicity. 
This insufficiency could have been related to either the image itself or to the 
prominence of the image in relation to the written vignette. For example, participants 
in this study could have spent the majority of their time reading the written vignette, 
only briefly glancing at the still image of the patient’s face. There is no way to know 
in this study whether this could be the case. However, this online study could have 
been configured in a way that would have required participants to view the patient’s 
face for a specified time period. In addition, the ethnicity of the computer-generated 
face could have been empirically validated, as well as emphasised in the written 
vignette.  
Alternatively, the use of videos of patients or actors portraying patients in pain 
(rather than a still image of a patient’s face) may have increased the ecological 
validity of the study, and potentially could have resulted in participants spending 
more time on visually viewing the patient before moving on to the written 
information. However, the use of these alternative stimuli would have also 
introduced many other confounding factors, and would not have allowed for the high 
level of control over facial expressions that was a feature of this study.  
The data that was gathered in this study about participants’ level of training in 
MUS, chronic pain or long-term conditions was non-specific and brief, and more 
detailed and specific information on this might have aided in the interpretation of 
results. No questions were asked about the content of the training, and the 
assessment of the length of training gave limited information (i.e. whether the 
training had a duration of more or less than one day). As a result, it is possible that 
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some of this training was for health conditions that are not primarily associated with 
pain, such as chronic obstructive pulmonary disease or diabetes. Equally, it is 
possible that most of the training received was of insufficient quality or length to 
adequately educate participants about the causal mechanisms and appropriate 
treatment of chronic pain.  As a result, more detailed information on the content and 
length of training would have been useful.  
Likewise, the data analysed about treatment decisions gave a broad picture of 
treatment preferences rather than a specific breakdown, and this study did not 
investigate the rationale that CBT therapists may have had for their treatment 
decisions. More specific information on treatment decisions could have been 
obtained by asking CBT therapists to indicate why they preferred some treatment 
options to others. For example, with regards to referring to specialist services, 
participants could have been given the option to indicate that a particular service 
was unavailable in their area, or that it had stringent referral criteria that they 
believed would not be met. Alternatively, when indicating a preference for a 
particular treatment model to use with the patient, participants could have been 
given the option to cite a reason for that preference (for example, believing that the 
patient would not engage with or benefit from a specific treatment).  
Finally, it is worth considering whether the methods of recruitment had an 
impact on the results of this study. As previously detailed, the original intention for 
this study was to recruit participants directly from nine primary care NHS services. 
However, recruitment was much lower than anticipated from conversations with 
service managers, and was therefore widened to social media and emails from CBT 
education providers. It is possible that recruiting through social media and email 
lists, rather than directly through participating services, means that more of the CBT 
therapists who chose to participate in this study did so because they were more 
interested (and therefore possibly better educated) in treating patients with chronic 
pain.  This could have had an impact on the results of this study, in which it was 
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hypothesised that less training and knowledge about medically unexplained 
symptoms and chronic pain could lead to unhelpful biases in pain judgments.  
5.6 Clinical and research implications 
5.6.1 Clinical implications 
If the results of this study are taken to mean that CBT therapists are 
influenced by biases and beliefs regarding patients with chronic pain and medically 
unexplained symptoms, then there are a number of implications for clinical practice. 
First and foremost, these results suggest that patients may have very different 
experiences of psychological therapy (in terms of recommended treatments and the 
stance of the therapist on their pain) based the presence or absence of a medical 
explanation for their symptoms. Decisions based on these factors have no scientific 
basis, and confirm the fears of many people who experience medically unexplained 
symptoms. 
Biased judgments for patients with chronic pain may lead to inappropriate 
treatments being offered, which in turn could lead to higher levels of patient dropout 
or poor response to inventions. At the very least, this would prevent patients with 
chronic pain from accessing an evidence-based treatment that could help them to 
better cope with their symptoms and reduce levels of disability and use of 
healthcare resources. At the very worst, this would lead to increased levels of 
distress in patients with chronic pain, which in turn could increase their levels of 
functional impairment and health resource use. These biases are also potentially 
self-confirming, in that higher levels of distress and dropout could perpetuate the 
view that people with medically unexplained symptoms primarily have a mental 
health difficulty and are difficult to engage and treat.  
Given the potential implications for patients, it is exceedingly important to 
address the biases that CBT therapists may hold about people with ‘medically 
unexplained’ symptoms or conditions as well as those from Asian ethnic 
backgrounds. Particularly if these biases are explicit, they may respond to better 
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education and training. Indeed, this study as well as previous research (Lewis, 
2011) indicates that CBT therapists in the UK could benefit from more training in 
medically unexplained symptoms and chronic pain. This training would need to be of 
sufficient quality and breadth in order to give CBT therapists adequate scientific 
knowledge about the mechanisms behind chronic pain and medically unexplained 
symptoms.  
However, previous research has found that education and training alone may 
not be enough to address implicit biases (Drwecki, Moore, Ward & Prkachin, 2011). 
A review of implicit bias in healthcare providers found a number of studies that used 
various strategies to successfully reduce bias (Chapman et al., 2013). Some of 
these strategies involved increasing clinicians’ awareness of their susceptibility to 
bias, as well as the provision of feedback regarding their potential biases in 
treatment decisions. The review also suggested that there is some evidence that, 
even without increased awareness, implicit bias can be reduced when clinicians 
have more information about the patient or are asked to focus on the individual 
qualities of the patient rather than the social and diagnostic categories that they 
belong to. Thus, CBT therapists may benefit from hearing people with chronic pain 
and medically unexplained symptoms describe their experiences and the impact of 
these on their daily lives.  
More broadly, it is likely that a wider shift in psychological thinking away from 
psychosomatic theories will be necessary, particularly in relation to chronic pain. 
Given the long history of these theories, the established complex interactions 
between psychosocial factors (mind) and ‘physical’ mechanisms of disease (body), 
and the surprising number of conditions and mechanisms that science continues to 
fail to explain, changing psychological perspectives to a more nuanced and scientific 
view of ‘medically unexplained’ conditions is likely to be a lengthy and difficult 
process that is frequently fraught with uncertainty. Nevertheless, this is an 
exceedingly important task. The more that CBT therapists are exposed to what is 
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known and not known about medically unexplained symptoms and chronic pain, the 
more likely they will be able to effectively intervene and support patients with these 
conditions.  
Healthcare policies and guidelines could play a part in bringing about this shift 
in thinking and reducing biases, particularly in light of their potential role in 
generating these biases that was highlighted in the introduction to this paper. 
Guidance documents should reflect our best evidence-based understandings of 
medically unexplained symptoms and chronic pain. They should also be careful 
about not inferring causal mechanisms from correlations between psychosocial 
stress and comorbid conditions in the diagnosis of medically unexplained 
symptoms.  
5.6.1 Research implications 
This study indicates that, as is found in medical professionals, CBT therapists 
may hold biased beliefs about people with medically unexplained symptoms and 
chronic pain. More research on these potential biases would be prudent, particularly 
in light of the recent government initiatives that push for more people with these 
difficulties to be referred for psychological therapy. 
In addition, this study provides evidence for stigma associated with diagnoses 
that are commonly described as medically unexplained (such as Chronic Fatigue 
Syndrome). Patients and patient advocacy groups have highlighted their 
experiences of this stigma, but there has been little research on this. This stigma 
could have an impact on the way that patients are viewed and treated by healthcare 
services and professionals, as well as by the general public. As a result, there is a 
need for further research in this area.  
6. Conclusion 
This study contributes to a wide body of research on the factors that trigger 
biases in healthcare providers’ judgments of pain and treatment decisions for 
patients of different ethnicities, and with chronic pain and ‘medically unexplained’ 
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symptoms. These findings provide evidence that CBT therapists judge pain to be 
less serious and more exaggerated when patients experience pain that is presented 
without a medical explanation, or is accompanied by a comorbid ‘medically 
unexplained’ condition. These factors were also found to have an impact on 
treatment decisions, with CBT therapists showing a stronger preference for 
treatment for depression when patients presented with medically unexplained 
symptoms. The ethnicity of the patient did not have a consistent effect in this study, 
but it was found to have an influence on CBT therapists’ treatment decisions, with a 
higher preference for treatment for depression for white patients over Asian patients. 
The potential implications for the treatment of patients with these factors are 
substantial, and many recommendations are made for the training and education of 
CBT providers in order to reduce biases.   
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In this critical appraisal, I will reflect on my experiences of conducting and 
reporting the systematic literature review and meta-analysis, as well as the empirical 
study.  I will explain how my perspective on ‘medically unexplained symptoms’ 
influenced the way I began this process, as well as how my views changed over 
time. I will also discuss the theoretical, semantic and practical challenges I faced, 
my attempts to overcome these difficulties, and my thoughts on how they could 
have been managed differently. 
1.   The start of the process 
My interest in chronic pain and ‘medically unexplained symptoms’ was 
fostered through personal experiences, as well as through three years of working in 
primary care psychology services (IAPT) prior to starting the DClinPsy. Throughout 
my time working in IAPT services, I assessed and attempted to offer interventions 
for many people who were ostensibly referred for low mood or anxiety, but 
presented with ‘unexplained’ physical symptoms or conditions as their primary 
difficulty. I met people who described experiencing chronic fatigue, chronic pain, 
gastroentestinal symptoms, tinnitis, and headaches, and heard about the enormous 
impact these symptoms could have on a person’s ability to live their life normally.  
These patients with ‘medically unexplained’ symptoms often described feeling 
unable to engage in activities such as work, activities with family and friends,  
exercise, or even getting out of bed in the morning. They also frequently expressed 
feelings of frustration with healthcare professionals who seemed dismissive, and 
were so often unable to offer any explanation or treatment for their difficulties. And, 
invariably, they would stress that these symptoms had affected their mental health, 
and not the other way around.  
 Hearing these stories of suffering from patients, and armed with – from my 
perspective – my minimal low-intensity IAPT training, my task was to offer an 
intervention that would improve their functioning and emotional wellbeing. In the 
resulting interactions, I would often feel two conflicting emotions. On the one hand, I 
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wholly believed in the experiences described to me and empathised with the 
enormous impact these symptoms had on patients’ lives. Nevertheless, as I 
attempted to implement any of the interventions I was trained to offer – increasing 
activity (i.e. behavioural activation), problem-solving, challenging unhelpful beliefs 
(i.e. cognitive restructuring) – I frequently experienced greater than usual difficulties, 
and the overall rate of ‘recovery’ for these patients was disappointingly low. As a 
result, I found myself in the curious position of feeling a great deal of empathy for 
these patients, but also experiencing a degree of trepidation and hopelessness 
when they ended up on my caseload.  
 As I gained further knowledge and experience in implementing psychological 
therapies through the DClinPsy training (including a Health Psychology placement), 
both my interest in chronic pain and medically unexplained symptoms, and my 
empathy for the people who struggle with these experiences grew. I realised that my 
lack of knowledge and experience in offering interventions for chronic pain and 
medically unexplained symptoms was probably the primary reason for my previous 
difficulties with these patients, and I became interested in using this experience to 
improve interventions. It was from this position, then, that I embarked on my 
literature review and empirical research.  
 Throughout the process of reviewing the literature on medically unexplained 
symptoms and chronic pain (in preparation for the empirical study as well as the 
meta-analysis), I became increasingly doubtful of the usefulness of ‘medically 
unexplained symptoms’ as a diagnostic category and label, as well as increasingly 
incredulous of the number of conditions that were described as ‘medically 
unexplained’, but actually had evidence-based causal mechanisms that were widely 
described in the literature. In addition, I became increasingly concerned about the 
role my profession had potentially played in perpetuating these misconceptions, and 
the impact this could have on patients. These issues (and my reasoning) are 
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covered extensively in both the literature review and meta-analysis, as well as in the 
report of my empirical research.  
 With this renewed sense of empathy and desire to advocate for patients with 
symptoms deemed to be ‘medically unexplained’, I decided to focus my literature 
review and empirical research on the effectiveness of psychological interventions 
and the judgments and treatment decisions of the people who implement them. And 
it was with this theoretical stance and strength of feeling that I approached the 
proposal, design and protocol for my empirical research. 
 Looking back on this process and the research protocol I produced, it is clear 
to me that I largely disregarded my own experiences, as well as the research on the 
struggles and dilemmas that healthcare professionals face when they are attempting 
to diagnose, effectively intervene, and communicate with people who experience 
symptoms that seem to be medically unexplained. When I read descriptions such as 
“heartsink patients” in the literature (Mathers, Jones, & Hannay, 1995), I interpreted 
that mostly as a failure of empathy on the part of healthcare professionals, rather 
than remembering my own struggles with that same feeling.  
 This failure to fully acknowledge the difficulties on both sides of the doctor-
patient relationship was evident in the rationale for my research presented in my 
proposal and protocol. As I went through the process of obtaining ethical approval 
through NHS Trusts and individual services, I received feedback questioning 
whether I was biased against CBT therapists. These comments led me to 
reevaluate the strength of my stance, and to think more carefully about the 
complexity and difficulties that both patients and professionals face when attempting 
to manage chronic pain and ‘medically unexplained’ symptoms.  
3. Negotiating a social minefield  
 Attempting to be more considered and diligent in my research, reasoning, 
and writing within the complex area of chronic pain and medically unexplained 
symptoms was a recurring theme for the remainder of my DClinPsy work. Often this 
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was an exceedingly difficult aim, as even when my reasoning was clear, it was often 
difficult to communicate my thinking in a way that would be of service to both 
professionals and patients and not risk misrepresenting, neglecting or offending 
either side. 
 I am not the first researcher to struggle with this issue, particularly in the 
controversial areas of chronic pain and medically unexplained symptoms. In my 
review of the literature, I read many reports of studies that neglected to fairly 
represent both professionals and patients either in the way the authors wrote about 
an issue or, more troubling, in the way that they interpreted and analysed their data. 
A number of these studies also attracted criticism from patients and patient 
advocates as well as from professionals.  
 This process of reviewing the literature increasingly reinforced in my mind 
the importance of having a clearly considered and communicated (and, as much as 
possible, evidence-based) rationale for my theoretical stance, research decisions, 
and analyses. Conducting research in a controversial area that has conflicting 
theoretical perspectives and real-world implications, particularly as someone who is 
new to the field, proved to be quite complicated when I was questioning ideas on 
which professional careers had been built and could potentially have a very real 
impact on the lives of patients. Thus, it felt imperitive to consider all sides in an 
unbiased and fair way.  
 At the same time, I recognised that the primary goal of this research was to, 
as far as is possible, conduct unbiased research and analyses that would have the 
potential to provide useful insights to professionals and benefit patients. Thus, if a 
particular finding or analysis led to a strong conclusion, it would not benefit either 
side to dillute the message in order reduce the risk of offence. Thus began a 
constant struggle in which I frequently became bogged down in making a clear 
argument, whilst ensuring that I fairly represented both sides.  
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4. Negotiating a semantic and theoretical minefield 
 In addition to my difficulties in ensuring that I communicated in a clear and 
fair way for both professionals and patients, I also struggled at a more fundamental 
level with the use of the term ‘medically unexplained symptoms’ (and any of the 
equivalent labels described in my review and empirical papers). My analysis of the 
literature and evidence-base for this term clearly led me to the conclusion that it was 
both an innacurate and misleading, as well a clinically and empirically unhelpful 
diagnostic label. 
 The biggest problem I had with the label was its broad and imprecise use to 
describe innumerable symptoms and conditions that medicine and science had yet 
to explain, and in some cases (as with chronic pain) had an evidence-based 
explanation but continued to be described as ‘unexplained’ (Williams & Johnson, 
2011). After examining the literature and evidence-base, I was not convinced that a 
patient with chronic pain experienced the same condition (or underlying causal 
mechanisms) as someone with tinnitis or chronic fatigue; nor was I certain that they 
would respond to the same interventions or components of interventions.  
 Thus, I found myself in the complicated position of conducting research on a 
diagnostic category that I did not have confidence in. This was particularly difficult 
when it came to writing the reports of my work, because it was important that I both 
clearly explained my theoretical stance as well as my rationale for using the 
diagnostic category in my research. This is certainly not a unique situation, and it is 
arguably most effective to work within a paradigm in order to raise questions about it 
and point out anomalies in the framework. However, it was nonetheless a difficult 
and time consuming process to ensure that I chose my words carefully and clearly 
communicated my arguments. 
  Negotiating this semantic and theoretical minefield was made further  
complicated by the need to communicate arguments about the mind (e.g. “mental” 
or psychological states) and body (e.g. “physical” or bodily states), without 
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suggested a dualistic position. The idea of mind-body dualism has been debated by 
philosophers since the time of Plato (and more recently by healthcare professionals 
and scientists) (Brown, 1988), and will not be detailed in full here. However, on a 
practical level, it was a challenge to balance the need to use terms like “mental” and 
“physical” to clearly communicate ideas, with the need to acknowledge that these 
are two interacting components of a whole human being (Duncan, 2000).  
5. Remembering the destination   
Being aware of, and attempting to manage these difficulties through careful 
thinking and writing was undoubtedly an important part of the process of conducting 
and reporting this research. However, there were times when I became nearly 
paralysed by these difficulties and struggled to think or write my way out of them. It 
was at these times, that it was helpful to remember why I had wanted to conduct this 
research in the first place.  
The overriding purpose of this research was to benefit patients. This benefit 
could be achieved by providing useful insights to scientists and professionals (e.g. 
CBT therapists) that would then contribute to improvements in research and clinical 
practice for patients with ‘medically unexplained symptoms’ or chronic pain. 
Alternatively, patients could benefit from direct consumption of the research, which 
could provide them with information about their condition and the effectiveness of 
available treatments, as well as insights about the way their experiences are 
conceptualised by professionals. However, in either case, the interests of patients 
should always come first.  
Remembering this purpose helped me to see my way through the semantic 
and theoretical minefield when I was feeling very stuck. And, although I am sure 
there are many improvements that could be made in the way that I have 
communicated my arguments, I am sure that always holding the patient in mind 
improved the work.  
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I would advise that future researchers, particularly in the complex field of 
‘medically unexplained symptoms’, spend a large proportion of their time in the 
planning stage ensuring that they are clear on their theoretical stance (and its 
strength and weaknesses) and the purpose of their research. Once you know where 
you are going and why you are going there, it becomes much easier to negotiate the 
journey. Remembering the purpose of what you are doing also helps you to avoid 
pitfalls like offending or seeming biased against the professionals you are working 
with, or interpreting results in a way that is a disservice to patients. And, even more 
importantly, it makes it easier to follow through on drawing strong conclusions when 
these are justified – even if this means stepping on a mine that you hoped to avoid.  
6. Reflections on practical challenges 
 Aside from the social, semantic and theoretical challenges throughout the 
process of this research, there were also practical challenges. One of these 
difficulties was in recruiting participants for the emprical research. The original plan 
for this study was to recruit CBT therapists directly from nine primary care 
psychological therapy services (IAPT services) in the NHS, and a great deal of time 
was spent gaining ethical approval and sponsorship through UCL, and then gaining 
additional ethical approval from the six different NHS Trusts that managed these 
services. 
 Not only did this process of gaining ethical approval introduce a signficant 
delay in the research, but there was then a very low level of participation from staff 
in these services. The online study had been designed with busy CBT therapist in 
mind, and was anticipated to take a maximum of 15 minutes to complete (actual 
completion times averaged about 7 minutes). Additional efforts were also made to 
engage the therapists in the research, with many of the services being visited and 
reminded multiple times about the research. However, after over a month of 
recruitment, only a fraction of the numbers anticipated through discussions with 
service managers had participated, and recruitment had to be widened through the 
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use of social media and emails from CBT education providers. In the end, half of the 
participants came from this additional recruitment.  
 This change in the recruitment method was concerning, as it potentially 
resulted in a different demographic of participants. It had been decided to recruit 
directly through NHS services in order to gain the most accurate picture of how the 
typical CBT therapist working in a non-specialist IAPT service would respond. 
Recruiting through social media and emails from CBT education providers 
potentially meant that CBT therapists with a larger interest or higher levels of 
training in chronic pain or medically unexplained symptoms were more likely to be 
recruited. Equally, CBT therapists from pilot IAPT services focusing on long-term 
health conditions could also have been more likely to respond. These changes in 
participant demographics could have changed the results of the study, but there is 
no way of knowing if this is the case from the data collected.  
 IAPT services are a potentially rich source of data for psychological 
research, primarily because they see large numbers of patients with a variety of 
difficulties, and are accustomed to regularly collecting outcome data. However, 
there is also a strong focus on cost-efficiency, and CBT therapists in IAPT services 
frequently have large caseloads and very busy schedules. As a result, service 
managers are often mindful of the additional pressures that participation in research 
can place on staff and the knock-on effect this can have on overall service 
performance targets.    
Possibly for these reasons, it was difficult to find service managers who 
would agree for their service to participate in this research, and it was also difficult to 
recruit the desired number of CBT therapists from the services that did agree to 
participate. Thus, with hindsight, I would have been much more conservative in my 
estimates of the number of CBT therapists that could be recruited from each 
service. In addition, I would only proceed with gaining the ethical approvals to  
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recruit directly from IAPT services if I was able to gain permission from enough 
services in order to meet the recruitment target.  
On a wider level, it would be beneficial if more researchers would engage 
with IAPT services. In my contacts with service managers, a number of them 
seemed to be surprised by my proposal to recruit their staff for research, and many 
were also unaware of their Trust’s protocols for conducting or participating in 
research. This indicates that, whilst they collect outcome data regularly, many IAPT 
services are not accustomed to participating in or conducting research. IAPT 
services are a potentially great resource for researchers, and it would be a shame 
for them not to be utilised.  
Equally, IAPT services are often under increasing pressure from 
commissioners and governments to provide efficient and effective interventions for a 
wide variety of difficulties (Commissioning Support for London, 2010; Department of 
Health, 2011, 2014). As a result, they stand to benefit a great deal from research 
that contributes to the evidence-base for interventions and provides insights into 
what treatments (and what components of these treatments) work best for particular 
patients and difficulties.  
7. Conclusion 
 Despite the challenges I have discussed here, I hope that those who are 
considering conducting research in chronic pain or medically unexplained symptoms 
(or even simply in IAPT services) are not discouraged from doing so. Engaging in 
the process of this research and learning to manage the many challenges has only 
increased my interest in this field. I hope that I will have more opportunities to 
contribute to the debate and evidence-base around medically unexplained 
symptoms in the future, and I hope that many others will join me.  
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Appendices 
 
Appendix 1: Example search strategy 
 
(CENTRAL)  
1. somatization OR somatization OR somatoform or hysteri* OR polysymptom* OR 
multisomatoform OR somatizer* 
2. (somatic NEAR symptom*) 
3. MUS OR MUPS OR “medical* unexplained” or “unexplained medical*”  
4. unexplained NEAR (symptom* or syndrome*) 
5. “frequent attend*” 
6. (multiple NEAR (“physical symptom*” or “symptom diagnos*)) 
7. neurastheni* 
8. function NEAR (disorder* OR symptom* OR syndrom* OR condition*) 
9. “chronic pain” OR “idiopathic pain” OR “unexplained pain” 
10. FMS OR fibromyalgia 
11. CFS OR “chronic fatigue” 
12. IBS OR “irritable bowel syndrome”  
13. “temporomandibular joint” OR TMJ 
14. (unexplained NEAR fatigue) 
15. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 
16. (CBT OR "cognitive behav* therap*" OR "cognitive therap*" OR "behav* therap*" 
OR "cognitive beh*" OR cognitive-beh*" OR cognitive NEAR (therapy OR treatment 
OR rehabilitation) OR behav* NEAR (therapy OR treatment OR rehabilitation)  
17. 15 and 16 
18. Limit: January 2005 to December 2015  
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Appendix 2: Ethical approval letter - UCL 
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Appendix 3: Confirmation of UCL sponsorship for recruitment in NHS Trusts 
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Appendix 4: Confirmation of NHS Trust Approval – BEH 
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Appendix 5: Confirmation of NHS Trust Approval – CNWL 
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Appendix 6: Confirmation of NHS Trust Approval – ELFT 
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Appendix 7: Confirmation of NHS Trust Approval –  
The Whittington Health NHS Trust 
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Appendix 8: Confirmation of NHS Trust Approval – NELFT 
 
 
 
 
  
 141 
 
Appendix 9: Confirmation of NHS Trust Approval – WLMHT 
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Appendix 10: Recruitment email 
 
 
 
Calling all CBT Therapists! 
 
With your ever-busy caseloads, have you ever wondered how you could possibly 
find the time to contribute to research and development for your field? 
 
Well here is your answer! 
 
We are looking for CBT Therapists to complete our online questionnaire looking at 
the factors that affect decisions in treating patients with chronic pain and 
depression.  
 
Click this link for more information and to access the study: 
https://uclpsych.eu.qualtrics.com/SE/?SID=SV_4PxStNGEXcH69iB 
 
Only 15 minutes of your time could make all the difference! 
 
If you have any questions or difficulties accessing the survey, please contact the 
research lead, Brittni Jones, at  
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Appendix 11: Online information sheet and consent form  
(Note: the Trust logo was changed or omitted depending on the recruitment source) 
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Appendix 12: Computer-generated patient faces and pain expressions 
 
 
White Face 1 – Expression A            Asian Face 1 – Expression A   
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
White Face 2 – Expression B                       Asian Face 2 – Expression B 
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White Face 3 – Expression C                       Asian Face 3 – Expression C 
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Appendix 13: Written vignettes 
 
 
 
Vignette 1: Medically explained pain only 
 
 is a 32-year-old woman who was referred to your service by her GP.  
  
The referral states that  visited her GP about 8 weeks ago complaining of back 
pain, and scans showed that she was suffering from a slipped disk in her spine. The 
GP notes that  seems to be depressed (low in mood, tearful, not engaging in 
enjoyable activities), and requests treatment for this.  
  
In her assessment,  reports that her low mood and back pain started a little 
over a year ago. She tells you that her back is intensely painful, and she feels 
unable to do the things she enjoys like walking her dog. She also finds it a struggle 
to do things she needs to do, such as carrying her shopping or washing the dishes. 
As a result of this,  reports that she has been feeling low in mood. 
 
 
Vignette 2: Medically unexplained pain only  
 
 is a 34-year-old woman who was referred to your service by her GP.  
  
The referral states that Sarah presented 6 weeks ago complaining of chronic back 
pain, but scans of her spine showed no abnormalities. The GP reports that  
seems to be experiencing symptoms of depression (low mood, difficulty sleeping, 
tearfulness), and he is referring her to your service for assessment and treatment of 
these difficulties.  
  
In the assessment,  tells you that her low mood and back pain both started 
about 1 year ago. She describes her back pain as intense and debilitating, and 
reports that it has made it difficult for her to do things she enjoys, like playing with 
her son, . She also says that she has found it increasingly difficult to 
engage in exercise and other physical activities. These limitations have left her 
feeling frustrated and low in mood. 
 
 
Vignette 3(a): Medically explained pain with comorbid CFS 
 
 is a 33-year-old woman who was referred to your service by her GP. 
  
The referral states that  visited her GP approximately 9 weeks ago, 
complaining of fatigue and chronic pain back pain. He explains that she was found 
to be suffering from a compressed nerve in her spine, and was also diagnosed with 
Chronic Fatigue Syndrome (CFS). The GP also notes that  seems to be 
depressed (low mood, tearfulness), and requests support for this.  
  
In her assessment,  says that her pain, fatigue and low mood started about 1.5 
years ago. She tells you that her pain and fatigue have been severe and debilitating, 
and that she has struggled to do the things she enjoys, such as going out to see 
friends and family.  reports that she finds it difficult to engage in physical 
activity, and has spent increasing amounts of time at home as a result.  
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Vignette 3(b): Medically unexplained pain with comorbid CFS 
 
 is a 33-year-old woman who was referred to your service by her GP. 
  
The referral states that  visited her GP approximately 9 weeks ago, 
complaining of fatigue and chronic pain back pain. He explains that no abnormalities 
were found in her scans, but she was diagnosed with Chronic Fatigue Syndrome 
(CFS). The GP also notes that  seems to be depressed (low mood, 
tearfulness), and requests support for this.  
  
In her assessment,  says that her pain, fatigue and low mood started about 1.5 
years ago. She tells you that her pain and fatigue have been severe and debilitating, 
and that she has struggled to do the things she enjoys, such as going out to see 
friends and family.  reports that she finds it difficult to engage in physical 
activity, and has spent increasing amounts of time at home as a result.   
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Appendix 14: Internet-based questions 
 
 
Part 1: Experiment Proper 
 
1.1 Directions 
 
1.2 Online questions (note: name of patient changed according to the vignette used) 
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Part 2: Participant information questions 
 
(Note: all options were selectable in the online format) 
 
 
